US5866363A
(en)
|
1985-08-28 |
1999-02-02 |
Pieczenik; George |
Method and means for sorting and identifying biological information
|
US5824469A
(en)
*
|
1986-07-17 |
1998-10-20 |
University Of Washington |
Method for producing novel DNA sequences with biological activity
|
US20060008806A1
(en)
*
|
1986-07-17 |
2006-01-12 |
University Of Washington |
Method for producing novel DNA sequence with biological activity
|
US5266684A
(en)
*
|
1988-05-02 |
1993-11-30 |
The Reagents Of The University Of California |
Peptide mixtures
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
CA2009996A1
(en)
*
|
1989-02-17 |
1990-08-17 |
Kathleen S. Cook |
Process for making genes encoding random polymers of amino acids
|
US7413537B2
(en)
|
1989-09-01 |
2008-08-19 |
Dyax Corp. |
Directed evolution of disulfide-bonded micro-proteins
|
EP0494955B1
(de)
*
|
1989-10-05 |
1998-07-15 |
Optein, Inc. |
Zellfreie synthese und isolierung von genen und polypeptiden
|
US5498538A
(en)
*
|
1990-02-15 |
1996-03-12 |
The University Of North Carolina At Chapel Hill |
Totally synthetic affinity reagents
|
DE69132902D1
(de)
*
|
1990-02-15 |
2002-02-21 |
Univ North Carolina Chapel Hill |
Methoden zur identifizierung heterofunktionaler fusionsproteine
|
US5747334A
(en)
*
|
1990-02-15 |
1998-05-05 |
The University Of North Carolina At Chapel Hill |
Random peptide library
|
US5427908A
(en)
*
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
US5639595A
(en)
*
|
1990-05-01 |
1997-06-17 |
Isis Phamaceuticals, Inc. |
Identification of novel drugs and reagents
|
US6465188B1
(en)
|
1990-06-11 |
2002-10-15 |
Gilead Sciences, Inc. |
Nucleic acid ligand complexes
|
US5811533A
(en)
*
|
1990-06-11 |
1998-09-22 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
|
US6127119A
(en)
*
|
1990-06-11 |
2000-10-03 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands of tissue target
|
US5726017A
(en)
*
|
1990-06-11 |
1998-03-10 |
Nexstar Pharmaceuticals, Inc. |
High affinity HIV-1 gag nucleic acid ligands
|
US5780228A
(en)
*
|
1990-06-11 |
1998-07-14 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands to lectins
|
US6030776A
(en)
*
|
1990-06-11 |
2000-02-29 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX
|
US5472841A
(en)
*
|
1990-06-11 |
1995-12-05 |
Nexstar Pharmaceuticals, Inc. |
Methods for identifying nucleic acid ligands of human neutrophil elastase
|
US5731424A
(en)
*
|
1990-06-11 |
1998-03-24 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands and inhibitors
|
US5270163A
(en)
*
|
1990-06-11 |
1993-12-14 |
University Research Corporation |
Methods for identifying nucleic acid ligands
|
US5837834A
(en)
*
|
1990-06-11 |
1998-11-17 |
Nexstar Pharmaceuticals, Inc. |
High affinity HKGF nucleic acid ligands and inhibitors
|
US5543293A
(en)
*
|
1990-06-11 |
1996-08-06 |
Nexstar Pharmaceuticals, Inc. |
DNA ligands of thrombin
|
US5654151A
(en)
*
|
1990-06-11 |
1997-08-05 |
Nexstar Pharmaceuticals, Inc. |
High affinity HIV Nucleocapsid nucleic acid ligands
|
US6232071B1
(en)
|
1990-06-11 |
2001-05-15 |
Gilead Sciences, Inc. |
Tenascin-C nucleic acid ligands
|
US5668264A
(en)
*
|
1990-06-11 |
1997-09-16 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
US5853984A
(en)
*
|
1990-06-11 |
1998-12-29 |
Nexstar Pharmaceuticals, Inc. |
Use of nucleic acid ligands in flow cytometry
|
US5686592A
(en)
*
|
1990-06-11 |
1997-11-11 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to immunoglobulin E (IgE)
|
US5731144A
(en)
*
|
1990-06-11 |
1998-03-24 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands
|
US5637682A
(en)
*
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to the tachykinin substance P
|
US5763566A
(en)
*
|
1990-06-11 |
1998-06-09 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue SELEX
|
US5629155A
(en)
*
|
1990-06-11 |
1997-05-13 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to immunoglobulin E (IgE)
|
US6001577A
(en)
*
|
1998-06-08 |
1999-12-14 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
US5962219A
(en)
|
1990-06-11 |
1999-10-05 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-selex
|
US20040132067A1
(en)
*
|
1990-06-11 |
2004-07-08 |
Somalogic, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
US5846713A
(en)
*
|
1990-06-11 |
1998-12-08 |
Nexstar Pharmaceuticals, Inc. |
High affinity HKGF nucleic acid ligands and inhibitors
|
US5693502A
(en)
*
|
1990-06-11 |
1997-12-02 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand inhibitors to DNA polymerases
|
US5707796A
(en)
*
|
1990-06-11 |
1998-01-13 |
Nexstar Pharmaceuticals, Inc. |
Method for selecting nucleic acids on the basis of structure
|
US5750342A
(en)
*
|
1990-06-11 |
1998-05-12 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands of tissue target
|
US5723289A
(en)
*
|
1990-06-11 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
Parallel selex
|
US5635615A
(en)
*
|
1990-06-11 |
1997-06-03 |
Nexstar Pharmaceuticals, Inc. |
High affinity HIV nucleocapsid nucleic acid ligands
|
US5972599A
(en)
*
|
1990-06-11 |
1999-10-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of cytokines
|
US6395888B1
(en)
|
1996-02-01 |
2002-05-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands of complement system proteins
|
US5637459A
(en)
*
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chimeric selex
|
US6696252B2
(en)
|
1990-06-11 |
2004-02-24 |
Gilead Sciences, Inc. |
High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
|
US5874218A
(en)
*
|
1990-06-11 |
1999-02-23 |
Nexstar Pharmaceuticals, Inc. |
Method for detecting a target compound in a substance using a nucleic acid ligand
|
US5660985A
(en)
*
|
1990-06-11 |
1997-08-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands containing modified nucleotides
|
US20060084797A1
(en)
*
|
1990-06-11 |
2006-04-20 |
Gilead Sciences, Inc. |
High affinity TGFbeta nucleic acid ligands and inhibitors
|
US6083696A
(en)
*
|
1990-06-11 |
2000-07-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands exponential enrichment: blended selex
|
US5648214A
(en)
*
|
1990-06-11 |
1997-07-15 |
University Research Corporation |
High-affinity oligonucleotide ligands to the tachykinin substance P
|
US5864026A
(en)
*
|
1990-06-11 |
1999-01-26 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US5527894A
(en)
*
|
1990-06-11 |
1996-06-18 |
Nexstar Pharmacueticals, Inc. |
Ligands of HIV-1 tat protein
|
US6465189B1
(en)
|
1990-06-11 |
2002-10-15 |
Gilead Sciences, Inc. |
Systematic evolution of ligands by exponential enrichment: blended selex
|
US5641629A
(en)
*
|
1990-06-11 |
1997-06-24 |
Nexstar Pharmacueticals Inc |
Spectroscopically detectable nucleic acid ligands
|
US5789163A
(en)
*
|
1990-06-11 |
1998-08-04 |
Nexstar Pharmaceuticals, Inc. |
Enzyme linked oligonucleotide assays (ELONAS)
|
US6140490A
(en)
*
|
1996-02-01 |
2000-10-31 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of complement system proteins
|
US5580737A
(en)
*
|
1990-06-11 |
1996-12-03 |
Nexstar Pharmaceuticals, Inc. |
High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
|
US5763173A
(en)
*
|
1990-06-11 |
1998-06-09 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand inhibitors to DNA polymerases
|
US5674685A
(en)
*
|
1990-06-11 |
1997-10-07 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
US6331394B1
(en)
|
1991-06-10 |
2001-12-18 |
Gilead Sciences, Inc. |
Nucleic acid ligands to integrins
|
US5459015A
(en)
*
|
1990-06-11 |
1995-10-17 |
Nexstar Pharmaceuticals, Inc. |
High-affinity RNA ligands of basic fibroblast growth factor
|
US6177557B1
(en)
|
1990-06-11 |
2001-01-23 |
Nexstar Pharmaceuticals, Inc. |
High affinity ligands of basic fibroblast growth factor and thrombin
|
US6610841B1
(en)
|
1997-12-18 |
2003-08-26 |
Gilead Sciences, Inc. |
Nucleotide-based prodrugs
|
US5503978A
(en)
*
|
1990-06-11 |
1996-04-02 |
University Research Corporation |
Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase
|
US6569620B1
(en)
|
1990-06-11 |
2003-05-27 |
Somalogic, Inc. |
Method for the automated generation of nucleic acid ligands
|
US6124449A
(en)
*
|
1990-06-11 |
2000-09-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands and inhibitors
|
US6261774B1
(en)
|
1990-06-11 |
2001-07-17 |
Gilead Sciences, Inc. |
Truncation selex method
|
US5869641A
(en)
*
|
1990-06-11 |
1999-02-09 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of CD4
|
WO1991019813A1
(en)
*
|
1990-06-11 |
1991-12-26 |
The University Of Colorado Foundation, Inc. |
Nucleic acid ligands
|
US5688935A
(en)
*
|
1990-06-11 |
1997-11-18 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands of tissue target
|
US6346611B1
(en)
|
1990-06-11 |
2002-02-12 |
Gilead Sciences, Inc. |
High affinity TGfβ nucleic acid ligands and inhibitors
|
US5837456A
(en)
*
|
1990-06-11 |
1998-11-17 |
Nexstar Pharmaceuticals, Inc. |
High affinity oligonucleotide ligands to chorionic gonadotropin hormone and related glycoprotein hormones
|
US5683867A
(en)
*
|
1990-06-11 |
1997-11-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: blended SELEX
|
US5587468A
(en)
*
|
1990-06-11 |
1996-12-24 |
University Research Corporation |
High affinity nucleic acid ligands to HIV integrase
|
US5496938A
(en)
|
1990-06-11 |
1996-03-05 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to HIV-RT and HIV-1 rev
|
US5874557A
(en)
*
|
1990-06-11 |
1999-02-23 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand inhibitors to DNA polymerases
|
US5861254A
(en)
*
|
1997-01-31 |
1999-01-19 |
Nexstar Pharmaceuticals, Inc. |
Flow cell SELEX
|
US6011020A
(en)
*
|
1990-06-11 |
2000-01-04 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand complexes
|
US6280932B1
(en)
|
1990-06-11 |
2001-08-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands to lectins
|
US5795721A
(en)
*
|
1990-06-11 |
1998-08-18 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of ICP4
|
US5756287A
(en)
*
|
1990-06-11 |
1998-05-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity HIV integrase inhibitors
|
US5705337A
(en)
*
|
1990-06-11 |
1998-01-06 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
US5766853A
(en)
*
|
1990-06-11 |
1998-06-16 |
Nexstar Pharmaceuticals, Inc. |
Method for identification of high affinity nucleic acid ligands to selectins
|
US5849890A
(en)
*
|
1990-06-11 |
1998-12-15 |
Nexstar Pharmaceuticals, Inc. |
High affinity oligonucleotide ligands to chorionic gonadotropin hormone and related glycoprotein hormones
|
US5789157A
(en)
*
|
1990-06-11 |
1998-08-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US5567588A
(en)
*
|
1990-06-11 |
1996-10-22 |
University Research Corporation |
Systematic evolution of ligands by exponential enrichment: Solution SELEX
|
US6001988A
(en)
*
|
1990-06-11 |
1999-12-14 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands to lectins
|
US5763177A
(en)
*
|
1990-06-11 |
1998-06-09 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
US6344321B1
(en)
*
|
1990-06-11 |
2002-02-05 |
Gilead Sciences, Inc. |
Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
|
US6759392B1
(en)
|
1990-06-11 |
2004-07-06 |
Gilead Sciences, Inc. |
High affinity RNA ligands of basic fibroblast growth factor
|
US5712375A
(en)
*
|
1990-06-11 |
1998-01-27 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US6716580B2
(en)
|
1990-06-11 |
2004-04-06 |
Somalogic, Inc. |
Method for the automated generation of nucleic acid ligands
|
US5723286A
(en)
*
|
1990-06-20 |
1998-03-03 |
Affymax Technologies N.V. |
Peptide library and screening systems
|
US6916605B1
(en)
*
|
1990-07-10 |
2005-07-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
US7063943B1
(en)
|
1990-07-10 |
2006-06-20 |
Cambridge Antibody Technology |
Methods for producing members of specific binding pairs
|
GB9015198D0
(en)
*
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US5843701A
(en)
*
|
1990-08-02 |
1998-12-01 |
Nexstar Pharmaceticals, Inc. |
Systematic polypeptide evolution by reverse translation
|
CA2105300C
(en)
|
1991-03-01 |
2008-12-23 |
Robert C. Ladner |
Process for the development of binding mini-proteins
|
US6028186A
(en)
*
|
1991-06-10 |
2000-02-22 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of cytokines
|
US6762290B1
(en)
|
1999-07-29 |
2004-07-13 |
Gilead Sciences, Inc. |
High affinity vascular endothelial growth factor (VEGF) receptor nucleic acid ligands and inhibitors
|
AU2313392A
(en)
*
|
1991-08-01 |
1993-03-02 |
University Research Corporation |
Systematic polypeptide evolution by reverse translation
|
US5733731A
(en)
*
|
1991-10-16 |
1998-03-31 |
Affymax Technologies N.V. |
Peptide library and screening method
|
US5270170A
(en)
*
|
1991-10-16 |
1993-12-14 |
Affymax Technologies N.V. |
Peptide library and screening method
|
PT1696031E
(pt)
*
|
1991-12-02 |
2010-06-25 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
US5656467A
(en)
*
|
1992-01-09 |
1997-08-12 |
The Trustees Of The University Of Pennsylvania |
Methods and materials for producing gene libraries
|
WO1993019170A1
(en)
*
|
1992-03-16 |
1993-09-30 |
Jacob Nathaniel Wohlstadter |
Selection methods
|
US5869644A
(en)
*
|
1992-04-15 |
1999-02-09 |
The Johns Hopkins University |
Synthesis of diverse and useful collections of oligonucleotidies
|
US5719273A
(en)
*
|
1993-06-14 |
1998-02-17 |
Nexstar Pharmaceuticals, Inc. |
Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide
|
US5998142A
(en)
*
|
1993-09-08 |
1999-12-07 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
US6458539B1
(en)
|
1993-09-17 |
2002-10-01 |
Somalogic, Inc. |
Photoselection of nucleic acid ligands
|
WO1995010296A1
(en)
*
|
1993-10-12 |
1995-04-20 |
Glycomed Incorporated |
A library of glyco-peptides useful for identification of cell adhesion inhibitors
|
US20060078561A1
(en)
*
|
1994-01-31 |
2006-04-13 |
The Trustees Of Boston University |
Polyclonal antibody libraries
|
DK0744958T3
(da)
|
1994-01-31 |
2003-10-20 |
Univ Boston |
Polyklonale antistofbiblioteker
|
US6165793A
(en)
|
1996-03-25 |
2000-12-26 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US6995017B1
(en)
|
1994-02-17 |
2006-02-07 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US6395547B1
(en)
|
1994-02-17 |
2002-05-28 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US20060257890A1
(en)
*
|
1996-05-20 |
2006-11-16 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US6335160B1
(en)
*
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US6309883B1
(en)
|
1994-02-17 |
2001-10-30 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US6117679A
(en)
|
1994-02-17 |
2000-09-12 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US7153948B2
(en)
|
1994-04-25 |
2006-12-26 |
Gilead Sciences, Inc. |
High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
|
US6682886B1
(en)
|
1994-04-28 |
2004-01-27 |
Gilead Sciences, Inc. |
Bivalent binding molecules of 7 transmembrane G protein-coupled receptors
|
US6010861A
(en)
*
|
1994-08-03 |
2000-01-04 |
Dgi Biotechnologies, Llc |
Target specific screens and their use for discovering small organic molecular pharmacophores
|
US6048698A
(en)
*
|
1994-09-20 |
2000-04-11 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX™
|
JPH10506463A
(ja)
*
|
1994-09-21 |
1998-06-23 |
サイトーゲン コーポレーション |
ペプチドライブラリー由来の抗原結合性ペプチド(アブチド)
|
US5885577A
(en)
*
|
1994-09-21 |
1999-03-23 |
Cytogen Corporation |
Antigen binding peptides (abtides) from peptide libraries
|
US6013443A
(en)
*
|
1995-05-03 |
2000-01-11 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue SELEX
|
WO1996034875A1
(en)
*
|
1995-05-03 |
1996-11-07 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US5859228A
(en)
*
|
1995-05-04 |
1999-01-12 |
Nexstar Pharmaceuticals, Inc. |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
US8071737B2
(en)
|
1995-05-04 |
2011-12-06 |
Glead Sciences, Inc. |
Nucleic acid ligand complexes
|
US20010053523A1
(en)
*
|
1995-06-02 |
2001-12-20 |
M&E Biotech A/S. |
Method for identification of biologically active peptides and nucleic acids
|
ES2276405T3
(es)
|
1995-06-02 |
2007-06-16 |
Gilead Sciences, Inc. |
Ligandos de oligonucleotidos de alta afinidad a pdgf.
|
US5723594A
(en)
*
|
1995-06-07 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
US6699843B2
(en)
|
1995-06-07 |
2004-03-02 |
Gilead Sciences, Inc. |
Method for treatment of tumors using nucleic acid ligands to PDGF
|
US20090118481A1
(en)
*
|
1995-06-07 |
2009-05-07 |
Gilead Sciences, Inc. |
High Affinity Nucleic Acid Ligands To Lectins
|
US6475806B1
(en)
|
1995-06-07 |
2002-11-05 |
Praecis Pharmaceuticals, Inc. |
Anchor libraries and identification of peptide binding sequences
|
US5797870A
(en)
*
|
1995-06-07 |
1998-08-25 |
Indiana University Foundation |
Pericardial delivery of therapeutic and diagnostic agents
|
US6183967B1
(en)
|
1995-06-07 |
2001-02-06 |
Nexstar Pharmaceuticals |
Nucleic acid ligand inhibitors to DNA polymerases
|
US6229002B1
(en)
|
1995-06-07 |
2001-05-08 |
Nexstar Pharmaceuticlas, Inc. |
Platelet derived growth factor (PDGF) nucleic acid ligand complexes
|
ES2321243T3
(es)
*
|
1995-06-07 |
2009-06-03 |
Gilead Sciences, Inc. |
Ligandos de acido nucleico que se unen a las adn polimerasas y las inhiben.
|
US6537776B1
(en)
|
1999-06-14 |
2003-03-25 |
Diversa Corporation |
Synthetic ligation reassembly in directed evolution
|
US5965408A
(en)
|
1996-07-09 |
1999-10-12 |
Diversa Corporation |
Method of DNA reassembly by interrupting synthesis
|
US6361974B1
(en)
|
1995-12-07 |
2002-03-26 |
Diversa Corporation |
Exonuclease-mediated nucleic acid reassembly in directed evolution
|
US7018793B1
(en)
|
1995-12-07 |
2006-03-28 |
Diversa Corporation |
Combinatorial screening of mixed populations of organisms
|
US6713279B1
(en)
|
1995-12-07 |
2004-03-30 |
Diversa Corporation |
Non-stochastic generation of genetic vaccines and enzymes
|
US5830696A
(en)
|
1996-12-05 |
1998-11-03 |
Diversa Corporation |
Directed evolution of thermophilic enzymes
|
US6358709B1
(en)
|
1995-12-07 |
2002-03-19 |
Diversa Corporation |
End selection in directed evolution
|
US20030219752A1
(en)
*
|
1995-12-07 |
2003-11-27 |
Diversa Corporation |
Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof
|
US6740506B2
(en)
|
1995-12-07 |
2004-05-25 |
Diversa Corporation |
End selection in directed evolution
|
US20020028443A1
(en)
*
|
1999-09-27 |
2002-03-07 |
Jay M. Short |
Method of dna shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process
|
US6352842B1
(en)
|
1995-12-07 |
2002-03-05 |
Diversa Corporation |
Exonucease-mediated gene assembly in directed evolution
|
US20020164580A1
(en)
*
|
1995-12-07 |
2002-11-07 |
Diversa Corporation |
Combinatorial screening of mixed populations of organisms
|
US6939689B2
(en)
|
1995-12-07 |
2005-09-06 |
Diversa Corporation |
Exonuclease-mediated nucleic acid reassembly in directed evolution
|
US6455247B1
(en)
*
|
1996-01-23 |
2002-09-24 |
Board Of Trustees Of The Leland Stanford Junior University |
Methods for screening for transdominant effector peptides and RNA molecules
|
US6365344B1
(en)
*
|
1996-01-23 |
2002-04-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for screening for transdominant effector peptides and RNA molecules
|
US6506602B1
(en)
|
1996-03-25 |
2003-01-14 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US6096548A
(en)
|
1996-03-25 |
2000-08-01 |
Maxygen, Inc. |
Method for directing evolution of a virus
|
US6699658B1
(en)
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6696251B1
(en)
|
1996-05-31 |
2004-02-24 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6300065B1
(en)
|
1996-05-31 |
2001-10-09 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6838238B1
(en)
|
1996-10-17 |
2005-01-04 |
Invitrogen Corporation |
Morphatides: novel shape and structure libraries
|
US6426335B1
(en)
*
|
1997-10-17 |
2002-07-30 |
Gilead Sciences, Inc. |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
JP2001504328A
(ja)
|
1996-10-31 |
2001-04-03 |
スミスクライン・ビーチャム・コーポレイション |
医薬上使用される化合物と結合するrna標的モチーフの特徴付けおよび選択の方法
|
US20070009930A1
(en)
*
|
1996-12-18 |
2007-01-11 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US6326204B1
(en)
|
1997-01-17 |
2001-12-04 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
US7148054B2
(en)
|
1997-01-17 |
2006-12-12 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
IL130635A0
(en)
|
1997-01-17 |
2000-06-01 |
Maxygen Inc |
Evolution of whole cells and organisms by recursive sequence recombination
|
CN1238366C
(zh)
|
1997-01-21 |
2006-01-25 |
综合医院公司 |
利用rna-蛋白融合体筛选蛋白
|
US6261804B1
(en)
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
US8207093B2
(en)
*
|
1997-01-21 |
2012-06-26 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
US5871924A
(en)
*
|
1997-01-27 |
1999-02-16 |
Nexstar Pharmaceuticals, Inc. |
Method for the production of ligands capable of facilitating aminoacyl-RNA synthesis
|
US6153410A
(en)
*
|
1997-03-25 |
2000-11-28 |
California Institute Of Technology |
Recombination of polynucleotide sequences using random or defined primers
|
US6180341B1
(en)
|
1997-05-01 |
2001-01-30 |
Board Of Regents, The Universiry Of Texas System |
In vitro scanning saturation mutagenesis of proteins
|
US7087420B1
(en)
|
1997-07-17 |
2006-08-08 |
Cambia |
Microbial β-glucuronidase genes, gene products and uses thereof
|
US6391547B1
(en)
*
|
1997-09-09 |
2002-05-21 |
Center For The Application Of Molecular Biology To International Agriculture |
Microbial β-glucuronidase genes, gene products and uses thereof
|
US6241701B1
(en)
|
1997-08-01 |
2001-06-05 |
Genetronics, Inc. |
Apparatus for electroporation mediated delivery of drugs and genes
|
US6670127B2
(en)
|
1997-09-16 |
2003-12-30 |
Egea Biosciences, Inc. |
Method for assembly of a polynucleotide encoding a target polypeptide
|
EP1030861A4
(de)
|
1997-10-31 |
2001-09-05 |
Maxygen Inc |
Modifizierung des virustropismius und des wirtspektrums durch virale genomdurchmischung
|
JP3712255B2
(ja)
|
1997-12-08 |
2005-11-02 |
カリフォルニア・インスティチュート・オブ・テクノロジー |
ポリヌクレオチドおよびポリペプチド配列を生成するための方法
|
US20060057573A1
(en)
|
2002-02-15 |
2006-03-16 |
Somalogic, Inc |
Methods and reagents for detecting target binding by nucleic acid ligands
|
US20070166741A1
(en)
|
1998-12-14 |
2007-07-19 |
Somalogic, Incorporated |
Multiplexed analyses of test samples
|
AU3909199A
(en)
|
1997-12-15 |
1999-07-05 |
Nexstar Pharmaceuticals, Inc. |
Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
|
US5989823A
(en)
|
1998-09-18 |
1999-11-23 |
Nexstar Pharmaceuticals, Inc. |
Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
|
US20030219803A1
(en)
*
|
1997-12-15 |
2003-11-27 |
Somalogic, Incorporated |
Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US6541011B2
(en)
|
1998-02-11 |
2003-04-01 |
Maxygen, Inc. |
Antigen library immunization
|
US7390619B1
(en)
*
|
1998-02-11 |
2008-06-24 |
Maxygen, Inc. |
Optimization of immunomodulatory properties of genetic vaccines
|
FR2782325B1
(fr)
*
|
1998-08-12 |
2002-05-24 |
Proteus |
Procede d'identification de sequences polynucleotidiques et/ou des proteines correspondantes a partir d'un echantillon d'acides nucleiques
|
US7157083B2
(en)
*
|
1998-04-17 |
2007-01-02 |
Surrogate Pharmaceutical Pathways, Llc |
Compositions and methods for treating retroviral infections
|
JP2002513550A
(ja)
|
1998-05-01 |
2002-05-14 |
マキシジェン, インコーポレイテッド |
Dnaシャッフリングを使用する病害虫抵抗性遺伝子の至適化
|
US7153655B2
(en)
*
|
1998-06-16 |
2006-12-26 |
Alligator Bioscience Ab |
Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
|
US6365408B1
(en)
|
1998-06-19 |
2002-04-02 |
Maxygen, Inc. |
Methods of evolving a polynucleotides by mutagenesis and recombination
|
IL140918A0
(en)
|
1998-07-27 |
2002-02-10 |
Genentech Inc |
Improved transformation efficiency in phage display through modification of a coat protein
|
US6602685B1
(en)
|
1998-08-17 |
2003-08-05 |
Phylos, Inc. |
Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
|
US6773911B1
(en)
|
1998-11-23 |
2004-08-10 |
Amgen Canada Inc. |
Apoptosis-inducing factor
|
US20020055626A1
(en)
*
|
2000-06-09 |
2002-05-09 |
Turner C. Alexander |
Novel human seven transmembrane proteins and polynucleotides encoding the same
|
US6570003B1
(en)
*
|
2001-01-09 |
2003-05-27 |
Lexion Genetics Incorporated |
Human 7TM proteins and polynucleotides encoding the same
|
AU774306B2
(en)
*
|
1999-01-05 |
2004-06-24 |
Trustees Of Boston University |
Improved nucleic acid cloning
|
AU2415200A
(en)
*
|
1999-01-18 |
2000-08-01 |
Maxygen, Inc. |
Methods of populating data structures for use in evolutionary simulations
|
US20030054390A1
(en)
*
|
1999-01-19 |
2003-03-20 |
Maxygen, Inc. |
Oligonucleotide mediated nucleic acid recombination
|
US20030054360A1
(en)
*
|
1999-01-19 |
2003-03-20 |
Larry Gold |
Method and apparatus for the automated generation of nucleic acid ligands
|
US20070065838A1
(en)
*
|
1999-01-19 |
2007-03-22 |
Maxygen, Inc. |
Oligonucleotide mediated nucleic acid recombination
|
US20090130718A1
(en)
*
|
1999-02-04 |
2009-05-21 |
Diversa Corporation |
Gene site saturation mutagenesis
|
US6329145B1
(en)
|
1999-02-09 |
2001-12-11 |
Gilead Science, Inc. |
Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligand
|
EP1165775A2
(de)
|
1999-03-05 |
2002-01-02 |
Maxygen, Inc. |
Rekombination von insertionsmodifizierten nucleinsäuren
|
US6703240B1
(en)
|
1999-04-13 |
2004-03-09 |
Maxygar, Inc. |
Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
|
US7332308B1
(en)
|
1999-05-21 |
2008-02-19 |
The Penn State Research Foundation |
Incrementally truncated nucleic acids and methods of making same
|
US6280943B1
(en)
*
|
1999-06-17 |
2001-08-28 |
Gilead Sciences, Inc. |
2′-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands
|
JP4737903B2
(ja)
|
1999-07-07 |
2011-08-03 |
ザイモジェネティクス, インコーポレイテッド |
ヒトサイトカイン受容体
|
US6387620B1
(en)
|
1999-07-28 |
2002-05-14 |
Gilead Sciences, Inc. |
Transcription-free selex
|
DE60042021D1
(de)
*
|
1999-07-29 |
2009-05-28 |
Gilead Sciences Inc |
Nukleinsäureliganden für den hepatozytischen wachstumsfaktor/dispersionsfaktor (hgf/sf) und seines c-met rezeptors
|
US7005260B1
(en)
|
2000-01-28 |
2006-02-28 |
Gilead Sciences, Inc. |
Tenascin-C nucleic acid ligands
|
US6171795B1
(en)
|
1999-07-29 |
2001-01-09 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to CD40ligand
|
US6506887B1
(en)
|
1999-07-29 |
2003-01-14 |
Somalogic, Incorporated |
Conditional-selex
|
US20020049312A1
(en)
*
|
2000-05-23 |
2002-04-25 |
Turner C. Alexander |
Noel human thrombospondin-like proteins and polynucleotides encoding the same
|
US6797510B1
(en)
*
|
2001-05-24 |
2004-09-28 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6541252B1
(en)
|
2000-05-19 |
2003-04-01 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6579710B2
(en)
*
|
2000-12-12 |
2003-06-17 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6841377B1
(en)
|
2001-06-13 |
2005-01-11 |
Lexicon Genetics Incorporated |
Human kinase and polynucleotides encoding the same
|
US6586230B1
(en)
*
|
2000-10-27 |
2003-07-01 |
Lexicon Genetics Incorporated |
Human kinase and polynucleotides encoding the same
|
US20080050809A1
(en)
*
|
1999-09-28 |
2008-02-28 |
Alejandro Abuin |
Novel human kinases and polynucleotides encoding the same
|
US6759527B2
(en)
|
2001-03-20 |
2004-07-06 |
Lexicon Genetics Incorporated |
Human kinase and polynucleotides encoding the same
|
US6849425B1
(en)
|
1999-10-14 |
2005-02-01 |
Ixsys, Inc. |
Methods of optimizing antibody variable region binding affinity
|
JP2003516755A
(ja)
*
|
1999-12-15 |
2003-05-20 |
ジェネンテック・インコーポレーテッド |
ショットガン走査、すなわち機能性タンパク質エピトープをマッピングするための組み合わせ方法
|
US7022479B2
(en)
*
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
JP2003520050A
(ja)
|
2000-01-24 |
2003-07-02 |
フィロス インク. |
タンパク質分析のための高感度多重化診断アッセイ法
|
AU5311701A
(en)
*
|
2000-01-26 |
2001-08-20 |
Lexicon Genetics Inc |
Novel human neurexin-like proteins and polynucleotides encoding the same
|
US20050239061A1
(en)
*
|
2000-03-01 |
2005-10-27 |
Marshall William S |
Identification and use of effectors and allosteric molecules for the alteration of gene expression
|
US7514239B2
(en)
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
AU2001289284A1
(en)
*
|
2000-04-04 |
2001-10-15 |
Enanta Pharmaceuticals, Inc. |
Methods for identifying peptide aptamers capable of altering a cell phenotype
|
ES2531551T3
(es)
*
|
2000-04-17 |
2015-03-17 |
Dyax Corp. |
Métodos para construir bibliotecas de presentación de paquetes genéticos para miembros de una familia diversa de péptido
|
US8288322B2
(en)
|
2000-04-17 |
2012-10-16 |
Dyax Corp. |
Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
|
US20020037506A1
(en)
*
|
2000-04-18 |
2002-03-28 |
Yun Lin |
Aptamer based two-site binding assay
|
US6479262B1
(en)
|
2000-05-16 |
2002-11-12 |
Hercules, Incorporated |
Solid phase enzymatic assembly of polynucleotides
|
WO2001094583A2
(en)
*
|
2000-06-07 |
2001-12-13 |
Lexicon Genetics Incorporated |
Human transporter proteins and polynucleotides encoding the same
|
US6465632B1
(en)
*
|
2000-06-09 |
2002-10-15 |
Lexicon Genetics Incorporated |
Human phosphatases and polynucleotides encoding the same
|
DE60137223D1
(de)
|
2000-06-28 |
2009-02-12 |
Amgen Inc |
Thymus-stroma lymphopoietin rezeptor-moleküle und deren verwendung
|
US6994963B1
(en)
|
2000-07-10 |
2006-02-07 |
Ambion, Inc. |
Methods for recombinatorial nucleic acid synthesis
|
AU2001273432A1
(en)
*
|
2000-07-13 |
2002-01-30 |
Invitrogen Corporation |
Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
|
WO2002008408A2
(en)
*
|
2000-07-21 |
2002-01-31 |
Trustees Of Boston University |
Modular vector systems
|
AU2001280968A1
(en)
*
|
2000-07-31 |
2002-02-13 |
Menzel, Rolf |
Compositions and methods for directed gene assembly
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
EP1311278A4
(de)
*
|
2000-08-07 |
2005-01-05 |
Sloan Kettering Institutefor C |
Methode und verbindungen zur immunisierung unter verwendung gemischter pools aus mutierten nukleinsäuren oder peptiden
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
JP2004506447A
(ja)
*
|
2000-08-22 |
2004-03-04 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒト7tmタンパクおよびそれをコードするポリヌクレオチド
|
AU2001285326A1
(en)
*
|
2000-08-31 |
2002-03-13 |
Lexicon Genetics Incorporated |
Human kinase proteins and polynucleotides encoding the same
|
US6376190B1
(en)
|
2000-09-22 |
2002-04-23 |
Somalogic, Inc. |
Modified SELEX processes without purified protein
|
EP1330544A4
(de)
*
|
2000-09-26 |
2005-04-06 |
Univ Duke |
Rna-aptamere und verfahren zu deren identifizierung
|
WO2002031745A1
(en)
*
|
2000-10-10 |
2002-04-18 |
Genencor International, Inc. |
Information rich libraries
|
CA2425605A1
(en)
|
2000-10-16 |
2002-04-25 |
Gilead Sciences, Inc. |
Nucleic acid ligands to the prostate specific membrane antigen
|
WO2002070705A2
(en)
*
|
2000-10-27 |
2002-09-12 |
Lexicon Genetics Incorporated |
Human 7tm proteins and polynucleotides encoding them
|
WO2002036633A2
(en)
*
|
2000-10-30 |
2002-05-10 |
Lexicon Genetics Incorporated |
Human 7tm proteins and polynucleotides encoding the same
|
AU2002228633A1
(en)
*
|
2000-11-20 |
2002-06-03 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US20020165149A1
(en)
*
|
2000-12-08 |
2002-11-07 |
Kranz David M. |
Mutated class II major histocompatibility proteins
|
CA2431007A1
(en)
*
|
2000-12-11 |
2002-07-18 |
Lexicon Genetics Incorporated |
Novel human kinase and polynucleotides encoding the same
|
US6958213B2
(en)
|
2000-12-12 |
2005-10-25 |
Alligator Bioscience Ab |
Method for in vitro molecular evolution of protein function
|
WO2002061071A2
(en)
|
2000-12-18 |
2002-08-08 |
Dyax Corp. |
Focused libraries of genetic packages
|
US6852844B1
(en)
|
2000-12-20 |
2005-02-08 |
Lexicon Genetics Incorporated |
Human protocadherin proteins and polynucleotides encoding the same
|
AU2002231736A1
(en)
|
2000-12-22 |
2002-07-08 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Use of repulsive guidance molecule (rgm) and its modulators
|
US20020086292A1
(en)
|
2000-12-22 |
2002-07-04 |
Shigeaki Harayama |
Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
|
AU2002246858A1
(en)
*
|
2000-12-27 |
2002-08-06 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
JP4061043B2
(ja)
|
2000-12-28 |
2008-03-12 |
株式会社ポストゲノム研究所 |
invitro転写/翻訳系によるペプチド等の製造方法
|
WO2002059287A2
(en)
*
|
2001-01-23 |
2002-08-01 |
Lexicon Genetics Incorporated |
Novel human kinases and polynucleotides encoding the same
|
US7582423B2
(en)
*
|
2001-02-02 |
2009-09-01 |
Novici Biotech Llc |
Population of polynucleotide sequence variants
|
US20040142433A1
(en)
*
|
2001-02-02 |
2004-07-22 |
Padgett Hal S. |
Polynucleotide sequence variants
|
WO2002079468A2
(en)
*
|
2001-02-02 |
2002-10-10 |
Large Scale Biology Corporation |
A method of increasing complementarity in a heteroduplex polynucleotide
|
US7838219B2
(en)
*
|
2001-02-02 |
2010-11-23 |
Novici Biotech Llc |
Method of increasing complementarity in a heteroduplex
|
US20020127587A1
(en)
*
|
2001-02-13 |
2002-09-12 |
Domenica Simms |
Methods and compositions for isolation of biological macromolecules
|
US20030175685A1
(en)
*
|
2001-02-22 |
2003-09-18 |
Praecis Pharmaceuticals Inc. |
Methods for identifying peptides which modulate a biological process
|
US6875845B2
(en)
|
2001-03-02 |
2005-04-05 |
Zymogenetics, Inc. |
Mouse cytokine receptor
|
US7807408B2
(en)
*
|
2001-03-19 |
2010-10-05 |
President & Fellows Of Harvard College |
Directed evolution of proteins
|
AU2002257076A1
(en)
|
2001-03-19 |
2002-10-03 |
President And Fellows Of Harvard College |
Nucleic acid shuffling
|
JP2004524043A
(ja)
|
2001-04-06 |
2004-08-12 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトキナーゼ及び該キナーゼをコードするポリヌクレオチド
|
WO2002081671A1
(en)
|
2001-04-06 |
2002-10-17 |
Lexicon Genetics Incorporated |
Novel human kinase and polynucleotides encoding the same
|
US6644173B2
(en)
*
|
2001-04-11 |
2003-11-11 |
Keuring, Incorporated |
Beverage filter cartridge holder
|
AU2002254773B2
(en)
*
|
2001-05-03 |
2005-12-08 |
Rensselaer Polytechnic Institute |
Novel methods of directed evolution
|
WO2002090517A2
(en)
*
|
2001-05-09 |
2002-11-14 |
Lexicon Genetics Incorporated |
Novel human kinases and polynucleotides encoding the same
|
US20020193585A1
(en)
*
|
2001-05-25 |
2002-12-19 |
Walke D. Wade |
Novel human transporter proteins and polynucleotides encoding the same
|
ATE482227T1
(de)
*
|
2001-05-25 |
2010-10-15 |
Univ Duke |
Modulatoren pharmakologischer mittel
|
CA2448347C
(en)
|
2001-05-29 |
2010-09-21 |
Lexicon Genetics Incorporated |
Novel human hydroxylases and polynucleotides encoding the same
|
US8740987B2
(en)
*
|
2001-06-04 |
2014-06-03 |
Warsaw Orthopedic, Inc. |
Tissue-derived mesh for orthopedic regeneration
|
US20030113714A1
(en)
*
|
2001-09-28 |
2003-06-19 |
Belcher Angela M. |
Biological control of nanoparticles
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
US20050164515A9
(en)
*
|
2001-06-05 |
2005-07-28 |
Belcher Angela M. |
Biological control of nanoparticle nucleation, shape and crystal phase
|
US20030148380A1
(en)
*
|
2001-06-05 |
2003-08-07 |
Belcher Angela M. |
Molecular recognition of materials
|
CA2633171C
(en)
|
2001-06-20 |
2012-11-20 |
Genentech, Inc. |
Antibodies against tumor-associated antigenic target (tat) polypeptides
|
DE10131441A1
(de)
*
|
2001-06-29 |
2003-01-30 |
Henkel Kgaa |
Eine neue Gruppe von alpha-Amylasen sowie ein Verfahren zur Identifizierung und Gewinnung neuer alpha-Amylasen
|
US20040204669A1
(en)
*
|
2001-07-05 |
2004-10-14 |
Hofmann Gunter A. |
Apparatus for electroporation mediated delivery for drugs and genes
|
CA2450236A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Genentech, Inc. |
Phage displayed pdz domain ligands
|
US6943001B2
(en)
*
|
2001-08-03 |
2005-09-13 |
Diversa Corporation |
Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
|
WO2003012126A2
(en)
*
|
2001-08-03 |
2003-02-13 |
Diversa Corporation |
Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
|
DE10138753B4
(de)
*
|
2001-08-07 |
2017-07-20 |
Henkel Ag & Co. Kgaa |
Wasch- und Reinigungsmittel mit Hybrid-Alpha-Amylasen
|
US7647184B2
(en)
*
|
2001-08-27 |
2010-01-12 |
Hanall Pharmaceuticals, Co. Ltd |
High throughput directed evolution by rational mutagenesis
|
DE60238143D1
(de)
|
2001-09-18 |
2010-12-09 |
Genentech Inc |
Zusammensetzungen und verfahren für die diagnose von tumoren
|
WO2003029456A1
(en)
|
2001-10-01 |
2003-04-10 |
Dyax Corp. |
Multi-chain eukaryotic display vectors and uses thereof
|
US20030073104A1
(en)
*
|
2001-10-02 |
2003-04-17 |
Belcher Angela M. |
Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
|
EP1840211A1
(de)
|
2001-10-31 |
2007-10-03 |
Danisco A/S |
Pyranoson Dehydratase aus phanerochaete Chrysosporium
|
AU2002346369B2
(en)
|
2001-11-14 |
2009-08-27 |
Eusa Pharma (Uk) Ltd |
Anti-IL-6 antibodies, compositions, methods and uses
|
DE60232688D1
(de)
*
|
2001-11-20 |
2009-07-30 |
Univ Duke |
Grenzflächen-biomaterialien
|
US6768476B2
(en)
*
|
2001-12-05 |
2004-07-27 |
Etenna Corporation |
Capacitively-loaded bent-wire monopole on an artificial magnetic conductor
|
AU2002359761A1
(en)
|
2001-12-18 |
2003-06-30 |
Invenux, Inc. |
Antibiotic compounds
|
WO2003057921A1
(en)
*
|
2001-12-26 |
2003-07-17 |
Sloan Kettering Institute For Cancer Research |
Dna immunization with libraries of minigenes encoding degenerate variants of major histocompatibility class i restricted epitopes
|
WO2003057160A2
(en)
|
2002-01-02 |
2003-07-17 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
WO2003064612A2
(en)
*
|
2002-01-28 |
2003-08-07 |
Sloan-Kettering Institute For Cancer Research |
Identification of mutant antigens with enhanced immunogenicity
|
US7078211B2
(en)
*
|
2002-02-01 |
2006-07-18 |
Large Scale Biology Corporation |
Nucleic acid molecules encoding endonucleases and methods of use thereof
|
US20030157495A1
(en)
*
|
2002-02-01 |
2003-08-21 |
Padgett Hal S. |
Nucleic acid molecules encoding CEL I endonuclease and methods of use thereof
|
US7662924B2
(en)
*
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
AU2003217693A1
(en)
*
|
2002-02-22 |
2003-09-09 |
Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
US20030166010A1
(en)
*
|
2002-02-25 |
2003-09-04 |
Affholter Joseph A. |
Custom ligand design for biomolecular filtration and purification for bioseperation
|
US20030224404A1
(en)
*
|
2002-02-25 |
2003-12-04 |
Manuel Vega |
High throughput directed evolution of nucleic acids by rational mutagenesis
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
MXPA04010092A
(es)
|
2002-04-16 |
2004-12-13 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores.
|
CA2481411C
(en)
|
2002-04-19 |
2016-06-14 |
Diversa Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
US7226771B2
(en)
|
2002-04-19 |
2007-06-05 |
Diversa Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
ES2285118T5
(es)
*
|
2002-05-17 |
2012-09-21 |
Alligator Bioscience Ab |
Un método para el desarrollo molecular in vitro de una función proteica.
|
EP1513879B1
(de)
*
|
2002-06-03 |
2018-08-22 |
Genentech, Inc. |
Bibliotheken synthetischer antikörperphagen
|
DE60319259T2
(de)
*
|
2002-06-14 |
2009-03-05 |
Dyax Corp., Cambridge |
Rekombination von nukleinsäurebibliotheksmitgliedern
|
AU2003247576A1
(en)
*
|
2002-06-18 |
2003-12-31 |
Archemix Corp. |
Aptamer-toxin molecules and methods for using same
|
AU2003261264B2
(en)
|
2002-07-25 |
2008-12-11 |
Archemix Corp. |
Regulated aptamer therapeutics
|
EP1576151A4
(de)
|
2002-08-06 |
2006-05-17 |
Verdia Inc |
Ap1-aminoxidase-varianten
|
US20040067532A1
(en)
*
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
US20050202438A1
(en)
*
|
2002-09-09 |
2005-09-15 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
US20060020396A1
(en)
*
|
2002-09-09 |
2006-01-26 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
ES2343518T3
(es)
*
|
2002-09-09 |
2010-08-03 |
Hanall Biopharma Co., Ltd. |
Polipeptidos interferon alfa modificados resistentes a proteasas.
|
US9303262B2
(en)
|
2002-09-17 |
2016-04-05 |
Archemix Llc |
Methods for identifying aptamer regulators
|
US20050064508A1
(en)
|
2003-09-22 |
2005-03-24 |
Semzyme |
Peptide mediated synthesis of metallic and magnetic materials
|
EP2364996B1
(de)
|
2002-09-27 |
2016-11-09 |
Xencor Inc. |
Optimierte FC-Varianten und Verfahren zu ihrer Erzeugung
|
JP3447009B1
(ja)
*
|
2002-10-29 |
2003-09-16 |
實 平垣 |
構築物用構成体およびその製造方法
|
US8853376B2
(en)
|
2002-11-21 |
2014-10-07 |
Archemix Llc |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
US10100316B2
(en)
|
2002-11-21 |
2018-10-16 |
Archemix Llc |
Aptamers comprising CPG motifs
|
WO2004047742A2
(en)
*
|
2002-11-21 |
2004-06-10 |
Archemix Corporation |
Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same
|
US20050124565A1
(en)
*
|
2002-11-21 |
2005-06-09 |
Diener John L. |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
US20040197804A1
(en)
*
|
2002-12-03 |
2004-10-07 |
Keefe Anthony D. |
Method for in vitro selection of 2'-substituted nucleic acids
|
US20050037394A1
(en)
*
|
2002-12-03 |
2005-02-17 |
Keefe Anthony D. |
Method for in vitro selection of 2'-substituted nucleic acids
|
EP1587831A2
(de)
*
|
2002-12-26 |
2005-10-26 |
Applied Research Systems ARS Holding N.V. |
Gespleisste varianten von lgr6
|
US20050079574A1
(en)
*
|
2003-01-16 |
2005-04-14 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
CN104388449A
(zh)
|
2003-03-06 |
2015-03-04 |
维莱尼姆公司 |
淀粉酶、编码它们的核酸及其制备和应用方法
|
CA2889013C
(en)
|
2003-03-07 |
2018-07-17 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
MXPA05010681A
(es)
|
2003-04-04 |
2005-12-15 |
Diversa Corp |
Liasas de pectato, acidos nucleicos que las codifican, y metodos para hacerlas y usarlas.
|
US20050250106A1
(en)
*
|
2003-04-24 |
2005-11-10 |
David Epstein |
Gene knock-down by intracellular expression of aptamers
|
US7964714B2
(en)
*
|
2003-05-12 |
2011-06-21 |
Potomac Pharmaceuticals Inc. |
Gene expression suppression agents
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
CN108486086A
(zh)
|
2003-07-02 |
2018-09-04 |
维莱尼姆公司 |
葡聚糖酶,编码它们的核酸以及制备和使用它们的方法
|
EP2277908A3
(de)
|
2003-07-08 |
2011-12-14 |
Genentech, Inc. |
Heterologe IL-17A/F-Polypeptide, Antikörper und deren therapeutische Verwendungen
|
EP2311994A1
(de)
*
|
2003-08-01 |
2011-04-20 |
Life Technologies Corporation |
Zusammensetzungen und Verfahren zur Aufreinigung kurzer RNA-Moleküle und anderer Nukleinsäuren
|
CA2534055A1
(en)
*
|
2003-08-01 |
2005-02-10 |
Genentech, Inc. |
Antibody cdr polypeptide sequences with restricted diversity
|
WO2005021714A2
(en)
|
2003-08-11 |
2005-03-10 |
Diversa Corporation |
Laccases, nucleic acids encoding them and methods for making and using them
|
CA2537055A1
(en)
*
|
2003-08-22 |
2005-04-21 |
Medimmune, Inc. |
Humanization of antibodies
|
JP2005065575A
(ja)
*
|
2003-08-22 |
2005-03-17 |
Japan Science & Technology Agency |
フレームシャッフリングによるタンパク質分子多様性集団の作製
|
US8399618B2
(en)
|
2004-10-21 |
2013-03-19 |
Xencor, Inc. |
Immunoglobulin insertions, deletions, and substitutions
|
US20060134105A1
(en)
*
|
2004-10-21 |
2006-06-22 |
Xencor, Inc. |
IgG immunoglobulin variants with optimized effector function
|
US8883147B2
(en)
|
2004-10-21 |
2014-11-11 |
Xencor, Inc. |
Immunoglobulins insertions, deletions, and substitutions
|
EP1689432B1
(de)
|
2003-11-17 |
2009-12-30 |
Genentech, Inc. |
Zusammensetzungen und verfahren zur behandlung von tumoren hämatopoetischen ursprungs
|
US20050112585A1
(en)
*
|
2003-11-21 |
2005-05-26 |
Dominic Zichi |
Method for adjusting the quantification range of individual analytes in a multiplexed assay
|
EP1697741A4
(de)
*
|
2003-12-04 |
2008-02-13 |
Xencor Inc |
Verfahren zur erzeugung von proteinvarianten mit erhöhtem wirtsstranggehalt und zusammensetzungen davon
|
PT3385384T
(pt)
|
2004-02-12 |
2020-06-30 |
Archemix Llc |
Terapêuticas com aptâmeros úteis no tratamento de desordens relacionadas com o complemento
|
US7803931B2
(en)
|
2004-02-12 |
2010-09-28 |
Archemix Corp. |
Aptamer therapeutics useful in the treatment of complement-related disorders
|
US20060193821A1
(en)
*
|
2004-03-05 |
2006-08-31 |
Diener John L |
Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics
|
CA2557633A1
(en)
*
|
2004-03-05 |
2005-09-22 |
Archemix Corp. |
Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
|
US7569223B2
(en)
*
|
2004-03-22 |
2009-08-04 |
The Rockefeller University |
Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions
|
EP2053062A1
(de)
|
2004-03-24 |
2009-04-29 |
Xencor, Inc. |
Immunoglobinvarianten außerhalb der Fc-Region
|
US7785903B2
(en)
*
|
2004-04-09 |
2010-08-31 |
Genentech, Inc. |
Variable domain library and uses
|
US20080214489A1
(en)
*
|
2004-04-19 |
2008-09-04 |
Anthony Dominic Keefe |
Aptamer-mediated intracellular delivery of oligonucleotides
|
AU2005238490B2
(en)
*
|
2004-04-22 |
2010-11-18 |
Tobira Therapeutics, Inc. |
Improved modulators of coagulation factors
|
US7579450B2
(en)
|
2004-04-26 |
2009-08-25 |
Archemix Corp. |
Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics
|
EP1745292A2
(de)
|
2004-04-28 |
2007-01-24 |
Bayer HealthCare AG |
Diagnositka und therapeutika für mit dipeptidyl-peptidase 1 (dpp1) assoziierten krankheiten
|
US20060292554A1
(en)
*
|
2004-05-18 |
2006-12-28 |
Genentech, Inc. |
Major coat protein variants for C-terminal and bi-terminal display
|
ES2540728T3
(es)
|
2004-06-16 |
2015-07-13 |
Dsm Ip Assets B.V. |
Método para la decoloración enzimática de feofitina
|
WO2006029258A2
(en)
*
|
2004-09-07 |
2006-03-16 |
Archemix Corp. |
Aptamer medicinal chemistry
|
US7566701B2
(en)
*
|
2004-09-07 |
2009-07-28 |
Archemix Corp. |
Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
|
EP1789096A4
(de)
|
2004-09-07 |
2009-07-08 |
Archemix Corp |
Aptamere für den von-willebrand-faktor und ihre verwendung als therapeutika für thrombotische erkrankungen
|
GB0422052D0
(en)
|
2004-10-04 |
2004-11-03 |
Dansico As |
Enzymes
|
GB0423139D0
(en)
|
2004-10-18 |
2004-11-17 |
Danisco |
Enzymes
|
EP2314618A3
(de)
|
2004-11-12 |
2011-10-19 |
Xencor Inc. |
Fc-Varianten mit modifizierter Bindung an FcRn
|
DK1772465T3
(da)
|
2005-01-05 |
2009-05-25 |
F Star Biotech Forsch & Entw |
Syntetiske immunoglobulindomæner med modificerede bindingsegenskaber i områder af molekylet, der ikke er komplementaritetsbestemmende regioner
|
PA8660701A1
(es)
|
2005-02-04 |
2006-09-22 |
Pfizer Prod Inc |
Agonistas de pyy y sus usos
|
WO2006086396A2
(en)
|
2005-02-08 |
2006-08-17 |
Zymogenetics, Inc. |
Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation
|
CA2614769A1
(en)
|
2005-03-10 |
2006-09-21 |
Verenium Corporation |
Lyase enzymes, nucleic acids encoding them and methods for making and using them
|
CN101175769A
(zh)
|
2005-03-10 |
2008-05-07 |
健泰科生物技术公司 |
用于调控血管完整性的方法和组合物
|
BRPI0609140A2
(pt)
|
2005-03-15 |
2010-02-17 |
Verenium Corp |
celulases, ácidos nucléicos que codificam eles e métodos para a produção e uso deles
|
JO3058B1
(ar)
|
2005-04-29 |
2017-03-15 |
Applied Molecular Evolution Inc |
الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها
|
WO2006124667A2
(en)
|
2005-05-12 |
2006-11-23 |
Zymogenetics, Inc. |
Compositions and methods for modulating immune responses
|
US20060271262A1
(en)
*
|
2005-05-24 |
2006-11-30 |
Mclain Harry P Iii |
Wireless agricultural network
|
WO2008018854A2
(en)
*
|
2005-06-06 |
2008-02-14 |
The Rockefeller University |
Bactiophage lysins for bacillus anthracis
|
US7582291B2
(en)
*
|
2005-06-30 |
2009-09-01 |
The Rockefeller University |
Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria
|
EP1896073B1
(de)
|
2005-06-30 |
2013-03-06 |
Janssen Biotech, Inc. |
Anti-il-23-antikörper, zusammensetzungen, verfahren und verwendung
|
EP1907421A4
(de)
*
|
2005-06-30 |
2012-03-28 |
Abbott Lab |
Il-12/p40-bindende proteine
|
SG2014010029A
(en)
|
2005-08-19 |
2014-08-28 |
Abbott Lab |
Dual variable domain immunoglobin and uses thereof
|
EP2500355A3
(de)
|
2005-08-19 |
2012-10-24 |
Abbott Laboratories |
Immunglobuline mit zweifacher variabler Domäne und ihre Verwendung
|
US20090215992A1
(en)
*
|
2005-08-19 |
2009-08-27 |
Chengbin Wu |
Dual variable domain immunoglobulin and uses thereof
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
EP2360248A1
(de)
|
2005-08-24 |
2011-08-24 |
The Rockefeller University |
PLY-GBS-mutante Lysine
|
US7713689B2
(en)
|
2005-09-15 |
2010-05-11 |
Duke University |
Non-fouling polymeric surface modification and signal amplification method for biomolecular detection
|
US8906864B2
(en)
*
|
2005-09-30 |
2014-12-09 |
AbbVie Deutschland GmbH & Co. KG |
Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use
|
ES2577292T3
(es)
|
2005-11-07 |
2016-07-14 |
Genentech, Inc. |
Polipéptidos de unión con secuencias hipervariables de VH/VL diversificadas y consenso
|
GB2432366B
(en)
*
|
2005-11-19 |
2007-11-21 |
Alligator Bioscience Ab |
A method for in vitro molecular evolution of protein function
|
RS53270B2
(sr)
|
2005-11-30 |
2018-05-31 |
Abbvie Deutschland |
Monoklonalna antitela protiv amiloidnog beta proteina i njihova upotreba
|
AU2006319358B2
(en)
*
|
2005-11-30 |
2012-01-19 |
AbbVie Deutschland GmbH & Co. KG |
Anti-Abeta globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
|
US20070237764A1
(en)
*
|
2005-12-02 |
2007-10-11 |
Genentech, Inc. |
Binding polypeptides with restricted diversity sequences
|
RS53685B1
(en)
|
2005-12-29 |
2015-04-30 |
Janssen Biotech Inc. |
HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND APPLICATIONS
|
EP2216403A3
(de)
|
2006-02-02 |
2010-11-24 |
Verenium Corporation |
Esterasen und dazugehörige Nukleinsäuren und Verfahren
|
WO2007092313A2
(en)
*
|
2006-02-03 |
2007-08-16 |
Indiana University Research And Technology Corporation |
Construction of open reading frame libraries and protein structures
|
NZ595498A
(en)
|
2006-02-10 |
2013-05-31 |
Verenium Corp |
Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
|
ES2682284T3
(es)
|
2006-02-14 |
2018-09-19 |
Bp Corporation North America Inc. |
Xilanasas, ácidos nucleicos que las codifican y métodos para elaborarlas y usarlas
|
CA2645225A1
(en)
|
2006-03-07 |
2007-09-13 |
Verenium Corporation |
Aldolases, nucleic acids encoding them and methods for making and using them
|
EP2316962B1
(de)
|
2006-03-07 |
2014-07-09 |
Cargill, Incorporated |
Adolasen, Nukleinsäuren, die diese codieren, und Verfahren zu deren Herstellung und Verwendung
|
HUE026496T2
(en)
*
|
2006-03-08 |
2016-06-28 |
Archemix Llc |
Complement-binding aptamers and anti-C5 agents for treating eye diseases
|
WO2007126455A2
(en)
|
2006-04-05 |
2007-11-08 |
Genentech, Inc. |
Method for using boc/cdo to modulate hedgehog signaling
|
WO2007134050A2
(en)
*
|
2006-05-09 |
2007-11-22 |
Genentech, Inc. |
Binding polypeptides with optimized scaffolds
|
AT503861B1
(de)
|
2006-07-05 |
2008-06-15 |
F Star Biotech Forsch & Entw |
Verfahren zur manipulation von t-zell-rezeptoren
|
AT503889B1
(de)
|
2006-07-05 |
2011-12-15 |
Star Biotechnologische Forschungs Und Entwicklungsges M B H F |
Multivalente immunglobuline
|
AT503902B1
(de)
|
2006-07-05 |
2008-06-15 |
F Star Biotech Forsch & Entw |
Verfahren zur manipulation von immunglobulinen
|
KR101193722B1
(ko)
|
2006-07-24 |
2013-01-11 |
바이오렉시스 파마슈티칼 코포레이션 |
엑센딘 융합 단백질
|
EP2444413A1
(de)
|
2006-08-04 |
2012-04-25 |
Verenium Corporation |
Verfahren für Öl- oder Gas-Bohrungen, Fluten und/oder "Fracturing"
|
AU2007284651B2
(en)
|
2006-08-09 |
2014-03-20 |
Institute For Systems Biology |
Organ-specific proteins and methods of their use
|
MY188368A
(en)
|
2006-09-08 |
2021-12-06 |
Abbott Lab |
Interleukin-13 binding proteins
|
WO2008032833A1
(fr)
|
2006-09-14 |
2008-03-20 |
Medical & Biological Laboratories Co., Ltd. |
Anticorps présentant une activité adcc accrue et son procédé de production
|
BRPI0716872A2
(pt)
|
2006-09-21 |
2015-06-16 |
Verenium Corp |
Fosfolipases, ácidos nucléicos codificando-as e métodos para fabricação e uso delas
|
EP2617819B1
(de)
|
2006-09-21 |
2016-04-27 |
BASF Enzymes LLC |
Phytasen, dafür kodierende Nukleinsäuren sowie Verfahren zu deren Herstellung und Verwendung
|
US9382327B2
(en)
*
|
2006-10-10 |
2016-07-05 |
Vaccinex, Inc. |
Anti-CD20 antibodies and methods of use
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
PL3101128T3
(pl)
|
2006-12-21 |
2019-09-30 |
Basf Enzymes Llc |
Amylazy i glukoamylazy, kwasy nukleinowe kodujące te związki oraz sposoby wytwarzania tych związków oraz stosowania ich
|
US7855054B2
(en)
|
2007-01-16 |
2010-12-21 |
Somalogic, Inc. |
Multiplexed analyses of test samples
|
US8975026B2
(en)
|
2007-01-16 |
2015-03-10 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
US20110136099A1
(en)
|
2007-01-16 |
2011-06-09 |
Somalogic, Inc. |
Multiplexed Analyses of Test Samples
|
US7964356B2
(en)
|
2007-01-16 |
2011-06-21 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
US7947447B2
(en)
|
2007-01-16 |
2011-05-24 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
CA2675366A1
(en)
*
|
2007-01-18 |
2008-07-24 |
University Of Southern California |
Gene polymorphisms predictive for dual tki therapy
|
NZ610301A
(en)
|
2007-01-30 |
2015-03-27 |
Bp Corp North America Inc |
Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
|
US8143046B2
(en)
|
2007-02-07 |
2012-03-27 |
Danisco Us Inc., Genencor Division |
Variant Buttiauxella sp. phytases having altered properties
|
AU2008218925A1
(en)
|
2007-02-20 |
2008-08-28 |
Anaptysbio, Inc. |
Somatic hypermutation systems
|
ES2556380T3
(es)
|
2007-02-22 |
2016-01-15 |
Genentech, Inc. |
Procedimientos para detectar una enfermedad inflamatoria del intestino
|
EP2486928A1
(de)
*
|
2007-02-27 |
2012-08-15 |
Abbott GmbH & Co. KG |
Verfahren zur Behandlung von Amyloidosen
|
PE20090329A1
(es)
*
|
2007-05-30 |
2009-03-27 |
Abbott Lab |
Anticuerpos humanizados contra el globulomero ab(20-42) y sus usos
|
US20090232801A1
(en)
*
|
2007-05-30 |
2009-09-17 |
Abbot Laboratories |
Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof
|
US20090203766A1
(en)
*
|
2007-06-01 |
2009-08-13 |
Archemix Corp. |
vWF aptamer formulations and methods for use
|
EP3241842B1
(de)
|
2007-06-26 |
2024-01-31 |
F-star Therapeutics Limited |
Präsentieren von bindenden mitteln
|
DK2489743T3
(en)
|
2007-07-17 |
2015-03-02 |
Somalogic Inc |
Aptamers with 5- (N-naphthyl) substituted uridines
|
EP2033971A1
(de)
*
|
2007-09-06 |
2009-03-11 |
Abbott GmbH & Co. KG |
Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung
|
WO2009036379A2
(en)
*
|
2007-09-14 |
2009-03-19 |
Adimab, Inc. |
Rationally designed, synthetic antibody libraries and uses therefor
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
DK2915564T3
(da)
|
2007-09-28 |
2021-02-08 |
Alexion Pharma Inc |
Antidoter mod faktor XA-inhibitorer og fremgangsmåder til anvendelse deraf
|
CN110577945A
(zh)
|
2007-10-03 |
2019-12-17 |
维莱尼姆公司 |
木聚糖酶、编码它们的核酸以及其制备和应用方法
|
JP2011502964A
(ja)
|
2007-10-23 |
2011-01-27 |
ザ レジェンツ オブ ザ ユニバーシティ オブ コロラド |
インバリアント鎖発現および/または異所性clip結合の競合的阻害剤
|
US8663980B2
(en)
*
|
2007-10-26 |
2014-03-04 |
Janssen Biotech, Inc. |
Vectors, host cells, and methods of production and uses
|
US8906700B2
(en)
|
2007-11-06 |
2014-12-09 |
Ambergen, Inc. |
Methods and compositions for phototransfer
|
EP2242843B1
(de)
*
|
2007-12-31 |
2015-05-27 |
XOMA Technology Ltd. |
Verfahren und material für gerichtete mutagenese
|
CN104651381A
(zh)
|
2008-01-03 |
2015-05-27 |
巴斯夫酶有限责任公司 |
转移酶和氧化还原酶、编码它们的核酸以及其制备和应用方法
|
EP2238261B1
(de)
|
2008-01-03 |
2013-12-04 |
Verenium Corporation |
Isomerasen, Nukleinsäuren zu ihrer Kodierung sowie Verfahren zu ihrer Herstellung und Verwendung
|
US7682809B2
(en)
|
2008-01-11 |
2010-03-23 |
Agilent Technologies, Inc. |
Direct ATP release sequencing
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
WO2009114815A1
(en)
|
2008-03-13 |
2009-09-17 |
Dyax Corp |
Libraries of genetic packages comprising novel hc cdr3 designs
|
EP2281078B1
(de)
*
|
2008-04-24 |
2014-10-22 |
Dyax Corporation |
Bibliotheken von genetischen packungen, umfassend neue hc-cdr1, -cdr2, und -cdr3, und neue lc-cdr1-, -cdr2- und -cdr3-designs
|
US20100260668A1
(en)
*
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
EP2282769A4
(de)
|
2008-04-29 |
2012-04-25 |
Abbott Lab |
Dual-variable- domain-immunglobuline und ihre verwendungen
|
DK2281034T3
(en)
|
2008-04-30 |
2016-01-25 |
Dupont Nutrition Biosci Aps |
A method using alcohol dehydrogenase Pseudoglucanobacter saccharoketogenes
|
EP2113255A1
(de)
|
2008-05-02 |
2009-11-04 |
f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. |
Zytotoxisches Immunglobulin
|
ES2579554T3
(es)
|
2008-05-09 |
2016-08-12 |
Abbvie Deutschland Gmbh & Co Kg |
Anticuerpos para el receptor de productos terminales de glicación avanzada (RAGE) y usos de los mismos
|
CA2725666A1
(en)
|
2008-06-03 |
2009-12-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
RU2010153580A
(ru)
|
2008-06-03 |
2012-07-20 |
Эбботт Лэборетриз (Us) |
Иммуноглобулины с двумя вариабельными доменами и их применение
|
CN102124030B
(zh)
*
|
2008-06-20 |
2015-06-17 |
国立大学法人冈山大学 |
抗氧化LDL/β2GPI复合物的抗体及其用途
|
EP2303318A2
(de)
|
2008-06-20 |
2011-04-06 |
Wyeth LLC |
Zusammensetzungen und verfahren zur verwendung von orf 1358 von beta-hämolytischen streptokokken-stämmen
|
JP5674654B2
(ja)
*
|
2008-07-08 |
2015-02-25 |
アッヴィ・インコーポレイテッド |
プロスタグランジンe2二重可変ドメイン免疫グロブリンおよびその使用
|
CN104829718A
(zh)
|
2008-07-08 |
2015-08-12 |
艾伯维公司 |
前列腺素e2结合蛋白及其用途
|
US8703416B2
(en)
|
2008-07-17 |
2014-04-22 |
Somalogic, Inc. |
Method for purification and identification of sperm cells
|
US20100166782A1
(en)
*
|
2008-07-25 |
2010-07-01 |
Martha Karen Newell |
Clip inhibitors and methods of modulating immune function
|
WO2010011315A2
(en)
*
|
2008-07-25 |
2010-01-28 |
Viral Genetics, Inc. |
Proteins for use in diagnosing and treating infection and disease
|
US9182406B2
(en)
*
|
2008-08-04 |
2015-11-10 |
Biodesy, Inc. |
Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
|
WO2010017598A1
(en)
|
2008-08-14 |
2010-02-18 |
Arana Therapeutics Limited |
Anti-il-12/il-23 antibodies
|
US8198062B2
(en)
|
2008-08-29 |
2012-06-12 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8357503B2
(en)
|
2008-08-29 |
2013-01-22 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8153391B2
(en)
|
2008-08-29 |
2012-04-10 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
JP5390621B2
(ja)
|
2008-10-20 |
2014-01-15 |
グワンジュ・インスティテュート・オブ・サイエンス・アンド・テクノロジー |
二座ペプチドバインダー
|
MX2011005953A
(es)
*
|
2008-12-04 |
2011-08-17 |
Abbott Lab |
Inmunoglobulinas de dominio variable dual y usos de las mismas.
|
EP2379720B1
(de)
|
2009-01-20 |
2016-08-17 |
Alona Zilberberg |
Durch den promoter mir-21 angetriebene gezielte krebstherapie
|
UA102722C2
(en)
*
|
2009-01-29 |
2013-08-12 |
Эббви Инк. |
Il-1 binding proteins
|
US20110165063A1
(en)
*
|
2009-01-29 |
2011-07-07 |
Abbott Laboratories |
Il-1 binding proteins
|
US8030026B2
(en)
*
|
2009-02-24 |
2011-10-04 |
Abbott Laboratories |
Antibodies to troponin I and methods of use thereof
|
US8835610B2
(en)
|
2009-03-05 |
2014-09-16 |
Abbvie Inc. |
IL-17 binding proteins
|
EP3604510A1
(de)
|
2009-03-30 |
2020-02-05 |
Portola Pharmaceuticals, Inc. |
Gegenmittel für faktor-xa-inhibitoren und verfahren zur verwendung davon
|
GB0908770D0
(en)
|
2009-04-24 |
2009-07-01 |
Danisco |
Method
|
MX355638B
(es)
|
2009-05-21 |
2018-03-26 |
Verenium Corp |
Fitasas, ácidos nucléicos que las codifican, y métodos de hacerlas y usarlas.
|
EP2453910B1
(de)
|
2009-07-15 |
2016-08-31 |
Portola Pharmaceuticals, Inc. |
Einzeldosisformulierung von antidoten für faktor-xa-hemmer zur prävention von blutung
|
TW201109438A
(en)
*
|
2009-07-29 |
2011-03-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
PE20121647A1
(es)
|
2009-08-29 |
2012-12-31 |
Abbvie Inc |
Proteinas terapeuticas de union a dll4
|
TW201119673A
(en)
|
2009-09-01 |
2011-06-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
CA2773564A1
(en)
*
|
2009-09-14 |
2011-03-17 |
Dyax Corp. |
Libraries of genetic packages comprising novel hc cdr3 designs
|
AU2010298036B2
(en)
|
2009-09-25 |
2015-05-21 |
Xoma Technology Ltd. |
Screening methods
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
TW201119676A
(en)
|
2009-10-15 |
2011-06-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
UA109884C2
(uk)
|
2009-10-16 |
2015-10-26 |
|
Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
|
UA111708C2
(uk)
|
2009-10-16 |
2016-06-10 |
Бандж Ойлз, Інк. |
Спосіб рафінування олії
|
CA2778442A1
(en)
|
2009-10-22 |
2011-04-28 |
Genentech, Inc. |
Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
|
UY32979A
(es)
*
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
WO2011053707A1
(en)
|
2009-10-31 |
2011-05-05 |
Abbott Laboratories |
Antibodies to receptor for advanced glycation end products (rage) and uses thereof
|
CN102741294A
(zh)
|
2009-11-30 |
2012-10-17 |
霍夫曼-拉罗奇有限公司 |
治疗和诊断表达slc34a2(tat211=seqid2)的肿瘤的抗体
|
CA2780069C
(en)
*
|
2009-12-08 |
2018-07-17 |
Abbott Gmbh & Co. Kg |
Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration
|
CA2789629A1
(en)
|
2010-02-10 |
2011-08-18 |
Immunogen, Inc. |
Cd20 antibodies and uses thereof
|
JP5981853B2
(ja)
|
2010-02-18 |
2016-08-31 |
ジェネンテック, インコーポレイテッド |
ニューレグリンアンタゴニスト及び癌の治療におけるそれらの使用
|
PE20130214A1
(es)
|
2010-02-23 |
2013-03-11 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores
|
JP5778700B2
(ja)
|
2010-02-24 |
2015-09-16 |
イミュノジェン, インコーポレイテッド |
フォレート受容体1抗体及びそのイムノコンジュゲート及び使用
|
SG10201501562VA
(en)
|
2010-03-02 |
2015-04-29 |
Abbvie Inc |
Therapeutic dll4 binding proteins
|
CA2808233C
(en)
|
2010-03-03 |
2017-07-11 |
Somalogic, Inc. |
Aptamers to 4-1bb and their use in treating diseases and disorders
|
CA2795043C
(en)
|
2010-03-30 |
2019-04-23 |
Janssen Biotech, Inc. |
Humanized il-25 antibodies
|
CN104069512A
(zh)
|
2010-04-12 |
2014-10-01 |
私募蛋白质体公司 |
针对β-NGF的适体及其在治疗β-NGF介导的疾病和失调中的用途
|
MX336196B
(es)
|
2010-04-15 |
2016-01-11 |
Abbvie Inc |
Proteinas de union a amiloide beta.
|
MX342239B
(es)
|
2010-05-03 |
2016-09-21 |
Genentech Inc * |
Composiciones y metodos para el diagnostico y tratamiento de tumores.
|
HUE033063T2
(hu)
|
2010-05-14 |
2017-11-28 |
Abbvie Inc |
IL-1 kötõ fehérjék
|
US20120009196A1
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
GB201011513D0
(en)
|
2010-07-08 |
2010-08-25 |
Danisco |
Method
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
DK3741883T3
(da)
|
2010-07-16 |
2023-02-20 |
Adimab Llc |
Antistofbiblioteker
|
CA2807014A1
(en)
|
2010-08-03 |
2012-02-09 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
WO2012024187A1
(en)
|
2010-08-14 |
2012-02-23 |
Abbott Laboratories |
Amyloid-beta binding proteins
|
US9505829B2
(en)
|
2010-08-19 |
2016-11-29 |
Zoetis Belgium S.A. |
Anti-NGF antibodies and their use
|
CA2809433A1
(en)
|
2010-08-26 |
2012-03-01 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
WO2012051055A2
(en)
|
2010-10-06 |
2012-04-19 |
Bp Corporation North America Inc. |
Variant cbh i polypeptides
|
RU2627171C2
(ru)
|
2010-12-21 |
2017-08-03 |
Эббви Инк. |
Il-1 альфа и бета биспецифические иммуноглобулины с двойными вариабельными доменами и их применение
|
US20120275996A1
(en)
|
2010-12-21 |
2012-11-01 |
Abbott Laboratories |
IL-1 Binding Proteins
|
DK2658970T3
(en)
|
2010-12-31 |
2017-01-16 |
Bioatla Llc |
Express humanization of antibodies
|
AU2012230899A1
(en)
|
2011-03-21 |
2013-10-10 |
Biodesy, Llc |
Classification of kinase inhibitors using nonlinear optical techniques
|
US9034322B2
(en)
|
2011-04-21 |
2015-05-19 |
The Rockefeller University |
Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
|
MX2014000531A
(es)
|
2011-07-13 |
2014-12-05 |
Abbvie Inc |
Metodos y composiciones para el tratamiento del asma usando anticuerpos anti-il-13.
|
WO2013016449A2
(en)
|
2011-07-26 |
2013-01-31 |
Indicator Systems International, Inc. |
Assays for the detection of microbes
|
BR112014005720A2
(pt)
|
2011-09-15 |
2017-12-12 |
Genentech Inc |
método de seleção e/ou identificação de um antagonista de usp1, antagonista de uaf1 e/ou um antagonista de id que promove uma alteração no destino celular do dito método
|
EP2764093B1
(de)
|
2011-10-05 |
2018-04-18 |
The Rockefeller University |
Dimere bacteriophagen-lysine
|
RU2014119426A
(ru)
|
2011-10-15 |
2015-11-20 |
Дженентек, Инк. |
Способы применения антагонистов scd1
|
AR088513A1
(es)
|
2011-10-24 |
2014-06-18 |
Abbvie Inc |
Inmunoenlazantes dirigidos contra esclerostina
|
JP6180425B2
(ja)
|
2011-11-23 |
2017-08-23 |
メディミューン,エルエルシー |
Her3に特異的な結合分子及びそれらの使用
|
CA2855570A1
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
US10118958B2
(en)
|
2011-12-14 |
2018-11-06 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
BR112014015851A2
(pt)
|
2011-12-30 |
2019-09-24 |
Abbvie Inc |
proteínas de ligação específicas duplas direcionadas contra il-13 e/ou il-17
|
WO2013109856A2
(en)
|
2012-01-18 |
2013-07-25 |
Genentech, Inc. |
Methods of using fgf19 modulators
|
PT2804878T
(pt)
|
2012-01-20 |
2018-11-29 |
Genzyme Corp |
Anticorpos anti-cxcr3
|
ES2676725T3
(es)
|
2012-01-27 |
2018-07-24 |
AbbVie Deutschland GmbH & Co. KG |
Composición y método para el diagnóstico y el tratamiento de enfermedades asociadas con la degeneración de las neuritas
|
EP2812350B1
(de)
|
2012-02-11 |
2019-04-03 |
F.Hoffmann-La Roche Ag |
R-spondin-translokationen und verfahren damit
|
US20140170159A9
(en)
|
2012-03-08 |
2014-06-19 |
Ge Wei |
Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof
|
EP3626254A1
(de)
|
2012-03-16 |
2020-03-25 |
University Health Network |
Lösliches toso protein und dessen verwendung zur behandlung von autoimmunerkrankungen
|
WO2013137920A1
(en)
|
2012-03-16 |
2013-09-19 |
Genentech, Inc. |
Engineered conformationally-stabilized proteins
|
CN104168898A
(zh)
|
2012-03-16 |
2014-11-26 |
霍夫曼-拉罗奇有限公司 |
以pak1抑制剂治疗黑色素瘤的方法
|
US9139863B2
(en)
|
2012-03-16 |
2015-09-22 |
Genentech, Inc. |
Engineered conformationally-stabilized proteins
|
US9592289B2
(en)
|
2012-03-26 |
2017-03-14 |
Sanofi |
Stable IgG4 based binding agent formulations
|
EP2841951B1
(de)
|
2012-04-25 |
2019-12-11 |
Biodesy, Inc. |
Verfahren zum nachweis von allosterischen proteinmodulatoren
|
WO2013170191A1
(en)
|
2012-05-11 |
2013-11-14 |
Genentech, Inc. |
Methods of using antagonists of nad biosynthesis from nicotinamide
|
SG11201408330XA
(en)
|
2012-05-24 |
2015-01-29 |
Mountgate Group Ltd |
Compositions and methods related to prevention and treatment of rabies infection
|
JP6629069B2
(ja)
|
2012-06-06 |
2020-01-15 |
ゾエティス・エルエルシー |
イヌ化抗ngf抗体およびその方法
|
US9670276B2
(en)
|
2012-07-12 |
2017-06-06 |
Abbvie Inc. |
IL-1 binding proteins
|
CA3137438A1
(en)
|
2012-08-31 |
2014-03-06 |
Immunogen, Inc. |
Diagnostic assays and kits for detection of folate receptor 1
|
SG11201503412RA
(en)
|
2012-11-01 |
2015-05-28 |
Abbvie Inc |
Anti-vegf/dll4 dual variable domain immunoglobulins and uses thereof
|
US9550986B2
(en)
|
2012-12-21 |
2017-01-24 |
Abbvie Inc. |
High-throughput antibody humanization
|
KR20150118159A
(ko)
|
2013-02-22 |
2015-10-21 |
에프. 호프만-라 로슈 아게 |
암의 치료 방법 및 약물 내성의 예방 방법
|
US9925240B2
(en)
|
2013-03-06 |
2018-03-27 |
Genentech, Inc. |
Methods of treating and preventing cancer drug resistance
|
GB201308828D0
(en)
|
2013-03-12 |
2013-07-03 |
Verenium Corp |
Phytase
|
BR112015023239A8
(pt)
|
2013-03-14 |
2018-04-17 |
Abbott Lab |
ensaio de combinação de anticorpo-antígeno de hcv e métodos e composições para uso do mesmo
|
GB201308843D0
(en)
|
2013-03-14 |
2013-07-03 |
Verenium Corp |
Phytase formulation
|
MX2015012824A
(es)
|
2013-03-14 |
2016-06-24 |
Abbott Lab |
Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos.
|
MX2015011606A
(es)
|
2013-03-14 |
2016-05-17 |
Genentech Inc |
Metodo para tratar cancer y prevenir resistencia a farmacos contra cancer.
|
JP6739329B2
(ja)
|
2013-03-14 |
2020-08-12 |
アボット・ラボラトリーズAbbott Laboratories |
Hcvコア脂質結合ドメインモノクローナル抗体
|
CN105324396A
(zh)
|
2013-03-15 |
2016-02-10 |
艾伯维公司 |
针对IL-1β和/或IL-17的双重特异性结合蛋白
|
MX2015011899A
(es)
|
2013-03-15 |
2016-05-05 |
Genentech Inc |
Metodos para el tratamiento de cáncer y prevención de resistencia a los fármacos para el cáncer.
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
AU2014235453A1
(en)
|
2013-03-15 |
2015-10-08 |
Genentech, Inc. |
Biomarkers and methods of treating PD-1 and PD-L1 related conditions
|
WO2014150914A2
(en)
|
2013-03-15 |
2014-09-25 |
Pioneer Hi-Bred International, Inc. |
Phi-4 polypeptides and methods for their use
|
JP6581572B2
(ja)
|
2013-06-07 |
2019-09-25 |
デューク ユニバーシティ |
補体因子h阻害薬
|
CA2919437A1
(en)
|
2013-07-25 |
2015-01-29 |
Basf Enzymes Llc |
Phytase
|
US10006045B2
(en)
|
2013-08-16 |
2018-06-26 |
Pioneer Hi-Bred International, Inc. |
Insecticidal proteins and methods for their use
|
IL293871A
(en)
|
2013-08-30 |
2022-08-01 |
Immunogen Inc |
Antibodies and assays for the detection of folate receptor 1
|
SG11201601770YA
(en)
|
2013-09-12 |
2016-04-28 |
Halozyme Inc |
Modified anti-epidermal growth factor receptor antibodies and methods of use thereof
|
CN105705007A
(zh)
|
2013-09-13 |
2016-06-22 |
先锋国际良种公司 |
杀昆虫蛋白及其使用方法
|
CA2935378C
(en)
|
2013-12-24 |
2023-04-18 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
RU2021113662A
(ru)
|
2014-02-07 |
2021-05-31 |
Пайонир Хай-Бред Интернэшнл, Инк. |
Инсектицидные белки и способы их применения
|
EP3102684B1
(de)
|
2014-02-07 |
2020-05-06 |
Pioneer Hi-Bred International, Inc. |
Insektizidproteine und verfahren zu deren verwendung
|
CA2941693A1
(en)
|
2014-03-07 |
2015-09-11 |
University Health Network |
Methods and compositions for detection of targets involved in cancer metastasis
|
RS60795B1
(sr)
|
2014-04-08 |
2020-10-30 |
Boston Pharmaceuticals Inc |
Vezujući molekuli specifični za il-21 i njihove upotrebe
|
BR112016022910A2
(pt)
|
2014-04-11 |
2017-10-17 |
Medimmune Llc |
anticorpos contra her2 biespecíficos
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
CA3225091A1
(en)
|
2014-05-05 |
2015-11-12 |
Regeneron Pharmaceuticals, Inc. |
Humanized c5 and c3 animals
|
RU2016144405A
(ru)
|
2014-05-23 |
2018-06-26 |
Дженентек, Инк. |
MiT БИОМАРКЕРЫ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
CN107073121A
(zh)
|
2014-06-13 |
2017-08-18 |
基因泰克公司 |
治疗及预防癌症药物抗性的方法
|
CN114057857A
(zh)
|
2014-06-20 |
2022-02-18 |
豪夫迈·罗氏有限公司 |
基于chagasin的支架组合物、方法和应用
|
CN107108705B
(zh)
|
2014-10-16 |
2021-05-25 |
先锋国际良种公司 |
杀昆虫蛋白及其使用方法
|
US20170306360A1
(en)
|
2014-10-24 |
2017-10-26 |
Danisco Us Inc. |
Method for producing alcohol by use of a tripeptidyl peptidase
|
CA2965438A1
(en)
|
2014-10-24 |
2016-04-28 |
Dupont Nutrition Biosciences Aps |
Use of proline tolerant tripeptidyl peptidases in feed additive compositions
|
MX2017005976A
(es)
|
2014-11-10 |
2017-06-29 |
Medimmune Ltd |
Moleculas de union especificas para grupo de diferenciacion 73 (cd73) y usos de las mismas.
|
EP3789403A1
(de)
|
2014-11-11 |
2021-03-10 |
MedImmune Limited |
Therapeutische kombinationen mit anti-cd73-antikörpern und a2a-rezeptorinhibitoren sowie verwendungen davon
|
WO2016094881A2
(en)
|
2014-12-11 |
2016-06-16 |
Abbvie Inc. |
Lrp-8 binding proteins
|
WO2016106286A1
(en)
|
2014-12-23 |
2016-06-30 |
Biodesy, Inc. |
Attachment of proteins to interfaces for use in nonlinear optical detection
|
CN107530423B
(zh)
|
2015-01-14 |
2022-04-05 |
布里格姆及妇女医院股份有限公司 |
用抗lap单克隆抗体治疗癌症
|
CA2977026A1
(en)
|
2015-03-11 |
2016-09-15 |
E.I. Du Pont De Nemours And Company |
Insecticidal combinations of pip-72 and methods of use
|
CN116063543A
(zh)
|
2015-04-24 |
2023-05-05 |
豪夫迈·罗氏有限公司 |
多特异性抗原结合蛋白
|
CN108064233B
(zh)
|
2015-05-19 |
2022-07-15 |
先锋国际良种公司 |
杀昆虫蛋白及其使用方法
|
PE20180193A1
(es)
|
2015-05-29 |
2018-01-26 |
Abbvie Inc |
Anticuerpos anti-cd40 y sus usos
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
CN107922497B
(zh)
|
2015-06-24 |
2022-04-12 |
詹森药业有限公司 |
抗vista抗体和片段
|
BR112017028035A2
(pt)
|
2015-06-26 |
2018-08-28 |
Dupont Nutrition Biosci Aps |
aminopeptidases para hidrolisados de proteína
|
JP7203497B2
(ja)
|
2015-06-29 |
2023-01-13 |
イミュノジェン・インコーポレーテッド |
抗cd123抗体、ならびにその複合体及び誘導体
|
WO2017011275A1
(en)
|
2015-07-10 |
2017-01-19 |
Nersissian Aram M |
Factor viii protein compositions and methods of treating hemophilia a
|
CA2993009A1
(en)
|
2015-07-31 |
2017-02-09 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
CN109475096B
(zh)
|
2015-08-06 |
2022-08-23 |
先锋国际良种公司 |
植物来源的杀昆虫蛋白及其使用方法
|
EP3365027B1
(de)
|
2015-10-14 |
2022-03-30 |
Research Institute at Nationwide Children's Hospital |
Hu-spezifische antikörper und deren verwendeng zur hemmung von biofilm
|
TWI726936B
(zh)
|
2015-11-10 |
2021-05-11 |
美商麥迪紐有限責任公司 |
對asct2具專一性之結合分子及其用途
|
EP3390431A1
(de)
|
2015-12-18 |
2018-10-24 |
Pioneer Hi-Bred International, Inc. |
Insektizide proteine und verfahren zu deren verwendung
|
CA3048204A1
(en)
|
2015-12-23 |
2017-06-29 |
Moonshot Pharma Llc |
Methods for inducing an immune response
|
TWI756204B
(zh)
|
2016-02-12 |
2022-03-01 |
比利時商楊森製藥公司 |
抗vista抗體及片段、其用途及鑑定其之方法
|
WO2017147060A1
(en)
|
2016-02-25 |
2017-08-31 |
Dupont Nutrition Biosciences Aps |
Method for producing a protein hydrolysate employing an aspergillus fumigatus tripeptidyl peptidase
|
JP6987072B2
(ja)
|
2016-03-10 |
2021-12-22 |
アクセレロン ファーマ インコーポレーテッド |
アクチビン2型受容体結合タンパク質及びその使用
|
WO2017161206A1
(en)
|
2016-03-16 |
2017-09-21 |
Halozyme, Inc. |
Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use
|
WO2017172771A2
(en)
|
2016-03-29 |
2017-10-05 |
Janssen Biotech, Inc. |
Method of treating psoriasis with increased interval dosing of anti-il12/23 antibody
|
WO2017175058A1
(en)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
CA3021334C
(en)
|
2016-04-27 |
2022-11-29 |
Abbvie Inc. |
Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies
|
CA3018384A1
(en)
|
2016-05-04 |
2017-11-09 |
Pioneer Hi-Bred International, Inc. |
Insecticidal proteins and methods for their use
|
MA51586A
(fr)
|
2016-06-02 |
2019-04-10 |
Abbvie Inc |
Agoniste du récepteur des glucocorticoïdes et immunoconjugués de celui-ci
|
CN109963870B
(zh)
|
2016-06-08 |
2023-07-28 |
艾伯维公司 |
抗b7-h3抗体和抗体药物偶联物
|
JP2019521973A
(ja)
|
2016-06-08 |
2019-08-08 |
アッヴィ・インコーポレイテッド |
抗bh7−h3抗体及び抗体薬物コンジュゲート
|
JP2019526529A
(ja)
|
2016-06-08 |
2019-09-19 |
アッヴィ・インコーポレイテッド |
抗b7−h3抗体及び抗体薬物コンジュゲート
|
GB201610198D0
(en)
|
2016-06-10 |
2016-07-27 |
Ucb Biopharma Sprl |
Anti-ige antibodies
|
EP3472186A1
(de)
|
2016-06-17 |
2019-04-24 |
National Hellenic Research Foundation |
Systeme zur rekombinanten proteinproduktion
|
WO2018005411A1
(en)
|
2016-07-01 |
2018-01-04 |
Pioneer Hi-Bred International, Inc. |
Insecticidal proteins from plants and methods for their use
|
JP2019534858A
(ja)
|
2016-09-09 |
2019-12-05 |
ジェネンテック, インコーポレイテッド |
Frizzledの選択的ペプチド阻害剤
|
CA3037961A1
(en)
|
2016-09-30 |
2018-04-05 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-il23 specific antibody
|
MX2019003473A
(es)
|
2016-10-03 |
2019-10-15 |
Abbott Lab |
Metodos mejorados para evaluar el estado de ubiquitin carboxi-terminal hidrolasa l1 (uch-l1) en muestras de pacientes.
|
EP3535285B1
(de)
|
2016-11-01 |
2022-04-06 |
Pioneer Hi-Bred International, Inc. |
Insektizide proteine und verfahren zu deren verwendung
|
KR20190078648A
(ko)
|
2016-11-16 |
2019-07-04 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체로 건선을 치료하는 방법
|
AU2017363309A1
(en)
|
2016-11-23 |
2019-07-11 |
Bioverativ Therapeutics Inc. |
Mono- and bispecific antibodies binding to coagulation factor IX and coagulation factor X
|
EP3544628A4
(de)
|
2016-11-23 |
2020-11-18 |
Immunoah Therapeutics, Inc. |
4-1bb-bindende proteine und verwendungen davon
|
CN110088123B
(zh)
|
2016-12-14 |
2023-10-20 |
先锋国际良种公司 |
杀昆虫蛋白及其使用方法
|
MX2019007491A
(es)
|
2016-12-22 |
2019-09-06 |
Pioneer Hi Bred Int |
Proteinas insecticidas y metodos para su uso.
|
CA3049105A1
(en)
|
2017-01-04 |
2018-07-12 |
Lauren O. Bakaletz |
Dnabii vaccines and antibodies with enhanced activity
|
WO2018129029A1
(en)
|
2017-01-04 |
2018-07-12 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
AU2018206560A1
(en)
|
2017-01-04 |
2019-07-18 |
Research Institute At Nationwide Children's Hospital |
Antibody fragments for the treatment of biofilm-related disorders
|
WO2018127791A2
(en)
|
2017-01-06 |
2018-07-12 |
Biosion, Inc. |
Erbb2 antibodies and uses therefore
|
EP3573658A4
(de)
|
2017-01-30 |
2021-07-21 |
Janssen Biotech, Inc. |
Anti-tnf-antikörper, zusammensetzungen und verfahren zur behandlung von aktiver psoriatischer arthritis
|
JP2020506947A
(ja)
|
2017-02-07 |
2020-03-05 |
ヤンセン バイオテツク,インコーポレーテツド |
活動性強直性脊椎炎を治療するための抗tnf抗体、組成物、及び方法
|
WO2018148001A1
(en)
|
2017-02-08 |
2018-08-16 |
Pioneer Hi-Bred International Inc |
Insecticidal combinations of plant derived insecticidal proteins and methods for their use
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
KR102602199B1
(ko)
|
2017-02-27 |
2023-11-15 |
리제너론 파아마슈티컬스, 인크. |
신장 및 간 장애의 인간화 모델
|
AU2018236271B2
(en)
|
2017-03-15 |
2023-12-21 |
Research Institute At Nationwide Children's Hospital |
Composition and methods for disruption of bacterial biofilms without accompanying inflammation
|
CA3052513A1
(en)
|
2017-03-23 |
2018-09-27 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
|
JP7344797B2
(ja)
|
2017-04-15 |
2023-09-14 |
アボット・ラボラトリーズ |
早期バイオマーカーを使用する、ヒト対象における外傷性脳損傷の、超急性の診断及び決定の一助となるための方法
|
EP3624820A1
(de)
|
2017-04-21 |
2020-03-25 |
H. Hoffnabb-La Roche Ag |
Verwendung von klk5-antagonisten zur behandlung einer krankheit
|
EP4230649A3
(de)
|
2017-04-25 |
2023-10-25 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Antikörper und verfahren zur diagnose und behandlung von epstein barr-virusinfektion
|
CN110603449A
(zh)
|
2017-04-28 |
2019-12-20 |
雅培实验室 |
用同一人受试者的至少两种样品的早期生物标记物帮助超急性诊断确定创伤性脑损伤的方法
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
BR112019023628A2
(pt)
|
2017-05-11 |
2020-06-02 |
Pioneer Hi-Bred International, Inc. |
Polipeptídeo inseticida recombinante, proteína inseticida quimérica, proteína de fusão, composição agrícola, polinucleotídeo recombinante, construto de dna, planta transgênica, método para inibir o crescimento ou exterminar uma praga de inseto ou população de praga, método para controlar os danos por praga de inseto, método para controlar infestação de praga e método para melhorar o rendimento de uma cultura
|
CN110651190A
(zh)
|
2017-05-25 |
2020-01-03 |
雅培实验室 |
用早期生物标记物帮助确定是否对已遭受或可能已遭受头部损伤的人受试者执行成像的方法
|
AU2018275235A1
(en)
|
2017-05-30 |
2019-10-31 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I and early biomarkers
|
EP3641752A4
(de)
|
2017-06-22 |
2021-03-17 |
Moonshot Pharma LLC |
Verfahren zur behandlung von krebs mit zusammensetzungen mit amlexanox und immunmodulatoren
|
EP3649474A1
(de)
|
2017-07-03 |
2020-05-13 |
Abbott Laboratories |
Verbesserte verfahren zur messung von ubiquitin-carboxy-terminalen hydrolase-l1-konzentrationen in blut
|
CN111094334A
(zh)
|
2017-07-19 |
2020-05-01 |
美国卫生与公众服务部 |
用于诊断和治疗乙肝病毒感染的抗体和方法
|
CN117050176A
(zh)
|
2017-07-31 |
2023-11-14 |
豪夫迈·罗氏有限公司 |
基于三维结构的人源化方法
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
EP3692370A2
(de)
|
2017-10-04 |
2020-08-12 |
OPKO Pharmaceuticals, LLC |
Artikel und verfahren zur personalisierten krebstherapie
|
WO2019075090A1
(en)
|
2017-10-10 |
2019-04-18 |
Tilos Therapeutics, Inc. |
ANTI-LAP ANTIBODIES AND USES THEREOF
|
JP2021502125A
(ja)
|
2017-11-09 |
2021-01-28 |
ピンテオン セラピューティクス インコーポレイテッド |
ヒト化コンホメーション特異的リン酸化タウ抗体の作製および使用のための方法および組成物
|
WO2019113525A2
(en)
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
|
WO2019112860A1
(en)
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of gfap and uch-l1
|
US20190211098A1
(en)
|
2017-12-22 |
2019-07-11 |
Genentech, Inc. |
Use of pilra binding agents for treatment of a disease
|
BR112020010430A2
(pt)
|
2017-12-29 |
2020-11-24 |
Abbott Laboratories |
biomarcadores e métodos inovadores para diagnosticar e avaliar lesão cerebral traumática
|
WO2019150309A1
(en)
|
2018-02-02 |
2019-08-08 |
Hammack Scott |
Modulators of gpr68 and uses thereof for treating and preventing diseases
|
CN111989117A
(zh)
|
2018-02-14 |
2020-11-24 |
维埃拉生物股份有限公司 |
麦克唐纳猫肉瘤(fms)样酪氨酸激酶3受体配体(flt3l)的抗体及其用于治疗自身免疫性疾病和炎性疾病的用途
|
KR20200129125A
(ko)
|
2018-03-05 |
2020-11-17 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체로 크론병을 치료하는 방법
|
WO2019177690A1
(en)
|
2018-03-12 |
2019-09-19 |
Zoetis Services Llc |
Anti-ngf antibodies and methods thereof
|
WO2019213619A1
(en)
|
2018-05-04 |
2019-11-07 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
EP3794116A2
(de)
|
2018-05-17 |
2021-03-24 |
BP Corporation North America Inc. |
Herstellung von 2-keto-3-deoxy-d-gluconsäure in filamentösen pilzen
|
TW202016144A
(zh)
|
2018-06-21 |
2020-05-01 |
日商第一三共股份有限公司 |
包括cd3抗原結合片段之組成物及其用途
|
WO2020014306A1
(en)
|
2018-07-10 |
2020-01-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
WO2020016838A2
(en)
|
2018-07-18 |
2020-01-23 |
Janssen Biotech, Inc. |
Sustained response predictors after treatment with anti-il23 specific antibody
|
WO2020041360A1
(en)
|
2018-08-21 |
2020-02-27 |
Quidel Corporation |
Dbpa antibodies and uses thereof
|
CN112969792A
(zh)
|
2018-09-07 |
2021-06-15 |
巴斯夫植物科学有限公司 |
用于在植物中产生高水平pufa的改进方法
|
CN113412332A
(zh)
|
2018-09-07 |
2021-09-17 |
巴斯夫植物科学有限公司 |
用于在植物中产生高水平pufa的改进方法
|
CA3110656A1
(en)
|
2018-09-07 |
2020-03-12 |
Basf Plant Science Company Gmbh |
Improved method for the production of high levels of pufa in plants
|
SI3883606T1
(sl)
|
2018-09-24 |
2023-10-30 |
Janssen Biotech, Inc. |
Varen in učinkovit postopek zdravljenja ulceroznega kolitisa s protitelesom proti IL12/IL23
|
CA3114925A1
(en)
|
2018-10-05 |
2020-04-09 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for enzymatic disruption of bacterial biofilms
|
WO2020076969A2
(en)
|
2018-10-10 |
2020-04-16 |
Tilos Therapeutics, Inc. |
Anti-lap antibody variants and uses thereof
|
US11548941B2
(en)
|
2018-11-20 |
2023-01-10 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-IL-23 specific antibody
|
EP3883961A1
(de)
|
2018-11-20 |
2021-09-29 |
Takeda Vaccines, Inc. |
Neuartige zika-virus-antikörper und ihre verwendungen
|
EP3897722A4
(de)
|
2018-12-18 |
2022-09-14 |
Janssen Biotech, Inc. |
Sichere und wirksame methode zur behandlung von lupus mit anti-il12/il23-antikörper
|
US20220090125A1
(en)
|
2018-12-21 |
2022-03-24 |
Compass Therapeutics Llc |
Transgenic mouse expressing common human light chain
|
EP3911676A1
(de)
|
2019-01-15 |
2021-11-24 |
Janssen Biotech, Inc. |
Anti-tnf-antikörperzusammensetzungen und verfahren zur behandlung von juveniler idiopathischer arthritis
|
KR20210118878A
(ko)
|
2019-01-23 |
2021-10-01 |
얀센 바이오테크 인코포레이티드 |
건선성 관절염의 치료 방법에 사용하기 위한 항-tnf 항체 조성물
|
MA55283A
(fr)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech Inc |
Procédés de production de compositions d'anticorps anti-tnf
|
KR20210141998A
(ko)
|
2019-03-14 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-tnf 항체 조성물의 제조 방법
|
MA55282A
(fr)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech Inc |
Procédés de fabrication pour la production de compositions d'anticorps anti-tnf
|
JP2022525145A
(ja)
|
2019-03-14 |
2022-05-11 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il12/il23抗体組成物を生成するための製造方法
|
EA202192459A1
(ru)
|
2019-03-18 |
2021-11-25 |
Янссен Байотек, Инк. |
Способ лечения псориаза антителом к il12/il23 у субъектов детского возраста
|
WO2020227554A1
(en)
|
2019-05-09 |
2020-11-12 |
Genentech, Inc. |
Methods of making antibodies
|
KR20220012883A
(ko)
|
2019-05-23 |
2022-02-04 |
얀센 바이오테크 인코포레이티드 |
Il-23 및 tnf 알파에 대한 항체의 병용요법으로 염증성 장질환을 치료하는 방법
|
CA3142580A1
(en)
|
2019-06-03 |
2020-12-10 |
Janssen Biotech, Inc. |
Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis
|
EP3976648A1
(de)
|
2019-06-03 |
2022-04-06 |
Janssen Biotech, Inc. |
Anti-tnf-antikörperzusammensetzungen und verfahren zur behandlung von aktiver psoriasis-arthritis
|
CA3145385A1
(en)
|
2019-07-08 |
2021-01-14 |
Steven D. Goodman |
Antibody compositions for disrupting biofilms
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
EP4077376A2
(de)
|
2019-12-19 |
2022-10-26 |
Quidel Corporation |
Monoklonale antikörperfusionen
|
BR112022011895A2
(pt)
|
2019-12-20 |
2022-09-06 |
Basf Se |
Diminuição da toxidez de terpenos e aumento da produção potencial em microrganismos
|
IL295387A
(en)
|
2020-02-05 |
2022-10-01 |
Larimar Therapeutics Inc |
Peptide-binding proteins and their uses
|
EP4132971A1
(de)
|
2020-04-09 |
2023-02-15 |
Merck Sharp & Dohme LLC |
Affinitätsgereifte anti-lap-antikörper und verwendungen davon
|
CA3175523A1
(en)
|
2020-04-13 |
2021-10-21 |
Antti Virtanen |
Methods, complexes and kits for detecting or determining an amount of a .beta.-coronavirus antibody in a sample
|
US20210338833A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Chimeric antigen receptor-targeting ligands and uses thereof
|
US20210340524A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
WO2021245064A1
(en)
|
2020-06-04 |
2021-12-09 |
Isobionics B.V. |
Synthetic santalene synthases
|
EP4182466A2
(de)
|
2020-07-14 |
2023-05-24 |
Pioneer Hi-Bred International, Inc. |
Insektizidproteine und verfahren zu deren verwendung
|
WO2022029494A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Rapid Diagnostics International Unlimited Company |
Assays for detecting sars-cov-2
|
EP4193149A1
(de)
|
2020-08-04 |
2023-06-14 |
Abbott Laboratories |
Verbesserte verfahren und kits zum nachweis von sars-cov-2-protein in einer probe
|
CA3193594A1
(en)
|
2020-09-11 |
2022-03-17 |
Medimmune Limited |
Therapeutic b7-h4 binding molecules
|
CA3194182A1
(en)
|
2020-09-12 |
2022-03-17 |
Medimmune Limited |
A scoring method for an anti-b7h4 antibody-drug conjugate therapy
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
US20220170948A1
(en)
|
2020-12-01 |
2022-06-02 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a human subject having received a head computerized tomography scan that is negative for a tbi
|
EP4015626A1
(de)
|
2020-12-18 |
2022-06-22 |
Isobionics B.V. |
Enzyme und verfahren zur fermentativen herstellung von monoterpenestern
|
EP4271998A1
(de)
|
2020-12-30 |
2023-11-08 |
Abbott Laboratories |
Verfahren zur bestimmung des sars-cov-2-antigens und anti-sars-cov-2-antikörpers in einer probe
|
JP2024503657A
(ja)
|
2021-01-13 |
2024-01-26 |
メモリアル スローン-ケタリング キャンサー センター |
抗体-ピロロベンゾジアゼピン誘導体コンジュゲート
|
KR20230146522A
(ko)
|
2021-01-13 |
2023-10-19 |
메모리얼 슬로안 케터링 캔서 센터 |
항-dll3 항체-약물 접합체
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
CA3212729A1
(en)
|
2021-03-12 |
2022-09-15 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriatic arthritis with anti-il23 specific antibody
|
AU2022232007A1
(en)
|
2021-03-12 |
2023-10-26 |
Janssen Biotech, Inc. |
Method of treating psoriatic arthritis patients with inadequate response to tnf therapy with anti-il23 specific antibody
|
CN117203232A
(zh)
|
2021-03-17 |
2023-12-08 |
瑞塞普托斯有限责任公司 |
用抗il-13抗体治疗特应性皮炎的方法
|
WO2022195028A2
(en)
|
2021-03-18 |
2022-09-22 |
Medimmune Limited |
Therapeutic binding molecules
|
EP4337689A1
(de)
|
2021-05-12 |
2024-03-20 |
Applied Biomedical Science Institute |
Bindungspolypeptide gegen sars cov-2 und verwendungen davon
|
CA3216320A1
(en)
|
2021-05-18 |
2022-11-24 |
Abbott Laboratories |
Methods of evaluating brain injury in a pediatric subject
|
AU2022276189A1
(en)
|
2021-05-20 |
2024-01-18 |
Janssen Biotech, Inc. |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
|
WO2022266034A1
(en)
|
2021-06-14 |
2022-12-22 |
Abbott Laboratories |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
US20230038355A1
(en)
|
2021-07-09 |
2023-02-09 |
Janssen Biotech, Inc. |
Manufacturing Methods for Producing Anti-IL12/IL23 Antibody Compositions
|
WO2023281462A1
(en)
|
2021-07-09 |
2023-01-12 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
KR20240032991A
(ko)
|
2021-07-09 |
2024-03-12 |
얀센 바이오테크 인코포레이티드 |
항-tnf 항체 조성물의 생성을 위한 제조 방법
|
CN117795087A
(zh)
|
2021-08-02 |
2024-03-29 |
巴斯夫欧洲公司 |
用紫罗兰亚基乙烷合酶进行的芳香化合物的新颖生产
|
US11807685B2
(en)
|
2021-08-05 |
2023-11-07 |
The Uab Research Foundation |
Anti-CD47 antibody and uses thereof
|
WO2023028186A1
(en)
|
2021-08-27 |
2023-03-02 |
Abbott Laboratories |
Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
|
CA3230038A1
(en)
|
2021-08-31 |
2023-03-09 |
Hongwei Zhang |
Methods and systems of diagnosing brain injury
|
AU2022354059A1
(en)
|
2021-09-30 |
2024-03-28 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023073615A1
(en)
|
2021-10-29 |
2023-05-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
US20230151087A1
(en)
|
2021-11-15 |
2023-05-18 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
US20230159633A1
(en)
|
2021-11-23 |
2023-05-25 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|
WO2023114978A1
(en)
|
2021-12-17 |
2023-06-22 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
US20230213536A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
TW202348252A
(zh)
|
2022-02-16 |
2023-12-16 |
英商梅迪繆思有限公司 |
用治療性結合分子治療癌症的組合療法
|
WO2023187707A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of treating mild to moderate psoriasis with il-23 specific antibody
|
WO2023223265A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for evaluating and treating psoriatic arthritis with il23 antibody
|
WO2024006876A1
(en)
|
2022-06-29 |
2024-01-04 |
Abbott Laboratories |
Magnetic point-of-care systems and assays for determining gfap in biological samples
|
WO2024059692A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|